Donate For Public and Patients Store Search

Welcome!

Search


Advocacy — Step therapy win in California

With your help, the AADA successfully advocated for step therapy legislation in California that would improve existing law around step therapy protocols.

Step therapy

The Academy opposes step therapy and “fail first” strategies because they impede treatment and have been shown to have a negative impact on patients. Step therapy blocks patient access to medications, interferes with the physician’s decision-making, and undermines the doctor-patient relationship.

Tackling step therapy

Too often, step therapy protocols interfere with your patients’ care and create unwanted burdens on your practice. Thanks to the AADA’s advocacy efforts, dozens of states have enacted step therapy reform laws, recognizing the value of a physician’s medical judgment.

State advocacy win: Step therapy reform enacted in Alaska

A step therapy and prior authorization reform bill enacted in Alaska will require insurers to establish a streamlined prior authorization process that minimizes administrative burdens on physicians. The legislation provided a clear and convenient process for requesting exceptions to step therapy protocols and conditions for automatic approval of step therapy

Step therapy legislation

Access Academy resources on state step therapy legislation. Step therapy has been shown to have a negative impact on patients, including delayed access to the most effective treatment, disease progression, and significant burdens on health care providers and their patients, as well as increases in health care costs.

AADA takes on step therapy reform, sunscreen access

New Jersey Gov. Phil Murphy (D) signed step therapy reform legislation into law, effective Jan. 1, 2026. The new law places guardrails around the use of step therapy protocols by state-regulated health plans, including Medicaid.

Playing the field: Introducing tirbanibulin for actinic keratosis therapy

Read the January 27, 2021 DermWorld Insights and Inquiries on tirbanibulin for actinic keratosis therapy.

Advocating for you — Tackling step therapy, formulary changes

Too often, step therapy protocols interfere with your patients’ care and create unwanted burdens on your practice.

Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid

Read the October 7, 2020 DermWorld Insights and Inquiries on targeted anti-complement therapy for bullous pemphigoid.

Advocating for you — Step Therapy Reform

You’ll have access to a clear, readily accessible, and convenient method to request a step-therapy override exception. The new laws are based on model legislation drafted by the AADA and other members of the State Access to Innovative Medicines Coalition. To date, 28 states have enacted step therapy reform laws.

Keeping you in the driver’s seat with step therapy and prior authorization reform

Too often, step therapy and prior authorization protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s advocacy efforts over the years, dozens of states have enacted step therapy reform laws. With more than half of the country recognizing the value of a physician’s

Topical retinoid therapy for acanthosis nigricans: In the thick of it

Read the December 11, 2019 DWII on topical retinoid therapy for acanthosis nigricans.

Coding for surface radiation therapy in dermatology: A practical guide

Understanding when and how to use new surface radiation therapy CPT codes 77436, 77437, 77438, and 77439, as well as services not to be reported in conjunction with the new codes, is essential for compliance and preventing inadvertent claim denial.

Advocating for you — Keeping you in the driver’s seat with step therapy reform

Due to our ongoing advocacy efforts in 2021, Nebraska is the most recent state to enact step therapy reform legislation. Additionally, our work resulted in improving existing laws in Arkansas, California, and Oregon.

Propranolol for infantile hemangiomas: Start to finish

Propranolol is first-line therapy for patients with infantile hemangiomas that warrant therapeutic intervention. Studies suggest that starting at the targeted dose and maintaining therapy until age 13 months and 3 months after the lesion has regressed may be appropriate management guidelines.

The illusions of IgG4-related skin disease

The diagnosis of IgG4-related skin disease requires careful clinical-pathological correlation because of its varied cutaneous presentations. B-cell depletion therapy with biologic agents such as inebilizumab or obexelimab is promising a future surpassing steroid therapy for this disease.

Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17

Access reporting information for QCDR measure AAD 17: Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.

August 19, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 19, 2026 ... Potassium hydroxide vs. diclofenac for actinic keratosis DermWorld What’s Hot: Increase in tanning for Gen Z Tirzepatide-associated morbilliform drug eruption Energy-based devices for acne in skin of

A potentially effective itsy-bitsy therapy for spider angiomas: Topical timolol

Spider angiomas are common lesions that may be secondary to underlying conditions, notably pregnancy or chronic liver disease. Although destructive modalities such as lasers are highly effective, topical timolol may be a valuable option for those who prefer a nonsurgical approach to therapy.

Highlighting the specialty in the nation’s capital

During the 2023 AADA Legislative Conference almost 200 attendees urged Congress to protect physician payment and implement step therapy reform.

Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176

This measure encourages tuberculosis (TB) prevention for patients receiving a first course of therapy using a biologic DMARD. Physicians should ensure TB prevention prior to treatment either through documenting a previous TB test or performing a TB test (PPD, IFN-gamma release assays, or other appropriate method) in the medical record

Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176

This measure encourages tuberculosis (TB) prevention for patients receiving a first course of therapy using a biologic DMARD. Physicians should ensure TB prevention prior to treatment either through documenting a previous TB test or performing a TB test (PPD, IFN-gamma release assays, or other appropriate method) in the medical record

Keeping dermatologists in the driver’s seat with step therapy reform

Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2023 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s

State advocacy support

Access Academy resources on state advocacy. These include finding your state society, step therapy, pending legislation, state grants, the Advocate of the Year Award, state advocacy priorities, and more.

Photobiomodulation: Seeing the light

DermWorld highlights the most popular (and effective) applications of red-light therapies, and how to advise patients about the proliferation of products for at-home use. ... Feature ... By Heidi Splete, Contributing Writer, December 1, 2025 Photobiomodulation (PBM) — including low-level laser therapy, low-light therapy, or red-light therapy — involves the

A presidential viewpoint: “Nobody knew that benign vascular lesions of the lip could be so complicated”

Well, maybe not as befuddling as replacing Obamacare, but there may be occasional difficulties in diagnosing benign vascular lesions of the lip, with implications for appropriate therapy.

Anticipating Iceland: Ice-pack dermatosis

Ice-pack dermatosis (IPD) usually presents on the lower back and buttocks as painful erythematous papules and plaques. Avoidance of ice packs is the cornerstone of therapy for this disorder.

Keeping you in the driver’s seat with step therapy and prior authorization reform

Moving the needle ... By Victoria Houghton, Managing Editor, November 1, 2022 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy and prior authorization protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks

Living with trimethylaminuria: Research awaiting the smell of success

Both primary and secondary trimethylaminuria can be socially debilitating. While dietary manipulation remains the cornerstone of treatment, our understanding of the disease may allow enzyme replacement or gene therapy for a brighter future.

March 11, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 11, 2026 ... Does home-use low-level laser therapy improve androgenetic alopecia? DermWorld What’s Hot: Is an oral IL-23 inhibitor on the way for psoriasis? Safety of the use of concomitant

Demystifying step therapy

Get familiar with the appeals process, your state’s laws, and what’s happening with reform efforts ... Feature ... By Emily Margosian, assistant editor, March 1, 2021 For many dermatologists, step therapy is an unwelcome and familiar hurdle, often requiring careful navigation of an onerous appeals process while patients fail to

Erectile dysfunction in dermatology: A silent epidemic

Erectile dysfunction (ED) is associated with chronic inflammatory disorders, including psoriasis, seborrheic dermatitis, hidradenitis suppurativa, atopic dermatitis, and others. Dermatologists can help ED patients by acknowledging these associations and assisting them in receiving appropriate therapy.

Impact Report — Vol 5, Issue 3

Your Academy continues to protect and advance our specialty where it matters most. We advocated for fair payment, defended against inappropriate step therapy protocols, raised the visibility of dermatology, expanded CME access, and strengthened our member community.

Low dose isotretinoin for recalcitrant rosacea: I pledge to use it sporadically

While rosacea can usually be reasonably managed with a combination of topical agents (metronidazole, azelaic acid, ivermectin, sulfacetamide, brimonidine), oral antibiotics (the tetracycline family), vascular lasers, intense pulsed light and surgery (for phymatous disease), some cases are recalcitrant to standard therapy.

Advocacy Update March 17, 2026

The AADA continues to encourage the FDA to implement the updated changes to the iPLEDGE program and continues to advocate for changes to Medicare Local Coverage Determinations (LCDs) governing the use of superficial radiation therapy.

Advocacy — 2021 AADA Virtual Legislative Conference

During the second annual AADA Virtual Legislative Conference, held on Sept. 23-28, we brought the most vital dermatologic issues to members of Congress, and it made a difference. Notably, more than 150 of you advocated for Medicare stability and step therapy reform.

Topical isotretinoin for ichthyoses: Striving for an “A” grade

Retinoids are standard therapy for patients with severe ichthyoses and disorders of keratinization. Dermatologists are familiar with the mucocutaneous and systemic adverse effects of oral isotretinoin. The promise of a safe and effective topical isotretinoin would be a welcome therapeutic advance.

An acne vaccine to make patients happy CAMPers?

When walking back to my office after receiving my flu shot, I thought about how wonderful it be to have a preventive therapy for common dermatologic disorders such as acne. That may not be so far-fetched.

Tinea gone wild: The emergence of Trichophyton indotineae as a global phenomenon

Trichophyton indotineae dermatophytosis is an extensive, recalcitrant disease frequently resistant to terbinafine, spreading worldwide. Dermatologists should consider this diagnosis when tinea infections do not respond to standard therapy and use itraconazole as the current treatment of choice.

February 11, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 11, 2026 ... Excision vs. topical 5-FU and photodynamic therapy in Bowen’s disease DermWorld What’s Hot: Sunscreen doping FDA confirms iPLEDGE changes Surgical interventions for hidradenitis suppurativa Is dual biologic

PBM advocacy wins for dermatology patients

With several wins for patient access to critical medications, the AADA continues to urge pharmacy benefit managers (PBMs) and payers to improve patient access to needed treatments and challenge payer use of step therapy, formulary changes, non-medical switching, and/or payer-mandated drug substitution.

Atopic dermatitis: Fantasizing about a dual approach

It has been acknowledged that we are on the cusp of biologic therapy for atopic dermatitis. My cadre of patients with severe atopic dermatitis (AD) are itching for its release – whenever that will be. Is there another pathway to alleviate pruritus? The itch meisters point to IL-31 as

Drug pricing and prior authorization

Access the Academy's resources and tools on drug pricing and prior authorization. Use an automated letter generator to ease the burden of seeking prior authorizations, or learn about the pitfalls of step therapy. Find drug prices in real time or access educational materials that you can share with your patients.

Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and Carteaud

Confluent and Reticulated Papillomatosis of Gougerot and Carteaud is usually seen in adolescents and young adults. Antibiotics (most commonly minocycline or doxycycline) are first-line therapy. The etiology of CARP remains to be determined, and further studies will judge its precise relationship to acanthosis nigricans.

Eruptive nevi: Trying to connect the dots

Eruptive nevi are striking – they may appear after a variety of disorders, including Stevens-Johnson/toxic epidermal necrolysis, primary blistering diseases, trauma, immunosuppression (from disease or iatrogenically-induced), PUVA therapy, or idiopathically. There are also several reports in the literature for eruptive Spitz nevi and blue nevi.

Working to enact step therapy reform in your state

Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2022 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Too often, step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Treatment decisions

May 8, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 8, 2024 ... A review of topical treatments for AK field therapy DermWorld Insights and Inquiries : Hard questions about subcutaneous fat necrosis of the newborn and hypercalcemia Derm Coding

Selectivity and the choice of beta-blockers for infantile hemangiomas

Has there ever been a more radical change in therapy following a serendipitous discovery than the use of propranolol for infantile hemangiomas (IHs)? Since the landmark report of Léauté-Labrèze in 2008 (1), propranolol has rapidly become the first-line treatment for IHs; nearly 800 papers detailing its use have been

Meaningful benefits — Quick coding guides

Not sure how to code for that insect bite or sting? We’ve got you covered. Need a photodynamic therapy code right now? We have that info too. Your Academy coding staff knows how busy you are in your practice, so we’ve developed several short and sweet tip sheets and guides

Joining the bullae pulpit: PD-1 inhibitors

As the use of immune checkpoint inhibitors has increased, so have the number of severe immunotherapy-related adverse events (irAEs). Although discontinuation of therapy may result in resolution of these untoward reactions, long-term sequelae and death have been reported. In a recently published systematic review encompassing 191publications reporting on 251 cases,

Share your experiences with delays or disruption to treatments

Have you experienced step therapy, prior authorization or non-medical switching and has it delayed you from accessing a necessary treatment? If so, then the AAD wants to hear from you. Also, please send us your contact information if you would be interested in testifying before your respective state legislature. It

May 7, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 7, 2025 ... Low-dose oral minoxidil vs. combination therapy with dutasteride or finasteride DermWorld Insights and Inquiries : Getting a head up on cutaneous scalp malignancies Academy mourns the passing

June 30, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 30, 2021 ... Treating atopic dermatitis with cognitive behavioral therapy: Does it work? DermWorld Insights and Inquiries : Deep learning in dermatopathology Sublingual tofacitinib for alopecia areata Biologic psoriasis treatments

Support system

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... Dermatologists step in to treat cutaneous side effects of cancer treatments so patients can complete their therapy ... By Ruth

Short anagen syndrome: The long and short of it

Short anagen syndrome (SAS) is an underrecognized disorder usually observed in children and typically resolves after puberty. It may be accompanied by psychological distress. Topical minoxidil and oral biotin may help therapeutically. Novel research has associated WNT10A variants with SAS and male pattern alopecia, opening the door for new areas

See the light in reporting phototherapy services

Derm Coding Consult ... By Cynthia Stewart, CPC, CPMA, COC, CPC-I, Manager, Coding and Reimbursement Resources, May 1, 2022 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . AAD/A Coding and Reimbursement staff have received several questions from

December 17, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 17, 2025 ... Antiandrogen therapy for female pattern hair loss DermWorld Insights and Inquiries : Long COVID has a lot of nerve Hidradenitis suppurativa treatment during pregnancy, lactation The role

April 19, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 19, 2023 ... Acne scars: Low-dose oral isotretinoin monotherapy vs. combined therapy with picosecond laser DermWorld Insights and Inquiries : No longer flailing with Flegel disease Academy mourns the passing

August 12, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 12, 2020 ... Treating trichotillomania: Beyond antidepressants DW Insights and Inquiries : Mogamulizumab for CTCL — Targeted therapy and immunotherapy crossing paths 2021 Medicare fee schedule rewards cognitive work, but

March 23, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 23, 2022 ... Acitretin: A new therapy for onychomycosis? DermWorld Insights and Inquiries : A new wrinkle in the diagnosis of cystic fibrosis? Injury and litigation in cutaneous laser surgery

February 19, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / February 19, 2025 ... Red and green LED light therapy in individuals with androgenetic alopecia DermWorld Insights and Inquiries : Treatments for renal IgA vasculitis are beginning to flow Safety of

March 2, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 2, 2022 ... Biotin beware: Physician, patient knowledge about lab interference DermWorld Insights and Inquiries : The rhythm of RIME Infections in children treated with dupilumab Cutaneous adverse events are

January 11, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 11, 2023 ... Antihistamines as adjunct therapy for alopecia areata DermWorld Insights and Inquiries : Acquisition and loss — A tribute to Jouni Uitto, MD, PhD Lidocaine shortage: Ask the

What's hot?

What's hot ... May 31, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... There are several FDA-approved options available for field therapy for the treatment of multiple actinic keratoses, including

Immune checkpoint inhibitor- induced lipodystrophy: Another affront to cancer patients

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, September 1, 2026 Vol. 8, No. 9 Cancer patients must cope with many indignities — physical, emotional, social, and economic. As targeted therapy is now a foundation of oncotherapy, dermatologists must keep abreast of new complications that can adversely

October 1, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 1, 2025 ... Antiandrogen therapy for the treatment of female pattern hair loss DermWorld Insights and Inquiries : Lupus miliaris disseminatus faciei — A Simon and Garfunkel playlist Academy mourns

Oral tranexamic acid to treat melasma: Are you bloody kidding me?

Tranexamic acid (TA) is a synthetic derivative of lysine utilized as an antifibrinolytic agent to prevent bleeding (for dental surgery in patients with hemophilia, post-cardiac bypass surgery patients, or in women with menorrhagia) and as a treatment option for hereditary angioedema.

More than 200 AADA members, patients ask Congress to halt Medicare payment cuts, reform step therapy

Facts at your fingertips ... By Emily Margosian, Assistant Editor, January 1, 2022 The second annual AADA Virtual Legislative Conference again saw impressive participation numbers this past September, bringing key dermatologic issues before members of Congress. Attendees included physicians, residents, select medical students, dermatology nurses, and patient advocates. ... Participating

An uphill battle

Pediatric dermatologists share struggles and successes obtaining treatments for their patients ... Feature ... By Allison Evans, Assistant Managing Editor, December 1, 2021 In a perfect world, a dermatologist would diagnose their patient’s condition and prescribe a therapy, and the patient would receive treatment. Unfortunately, in reality, dermatologists diagnose a

Avoid the opioid

Experts offer advice on effective pain management in dermatology. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2026 Many dermatoses and dermatologic procedures are painful, but consensus on pain management in dermatology is limited, and complicated not only by the individual and varied experience of pain, but also

COVID’s impact on cosmetic procedures

Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release

December 4, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 4, 2024 ... What’s the best treatment for squamous cell carcinoma in situ? DermWorld Insights and Inquiries : Darier disease is rough clinically and therapeutically. MEK inhibition may offer a

March 4, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March. 4, 2026 ... Flutamide for hair loss DermWorld Insights and Inquiries : Eosinophilic pustular folliculitis — Six decades of progress A novel application of punch excision therapy for keloids Migraine

January 14, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 14, 2026 ... Are light-based therapies effective for hair loss? DermWorld What’s hot : Local recurrence and survival in patients with melanoma in situ Strategies to reduce the risk of

July 15, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 15, 2026 ... Oral minoxidil: 2.5 mg vs. 5 mg for male androgenetic alopecia DermWorld What’s Hot: Use of compounded sterile preparations Malignancy risk with biologics vs. topical therapy for

Can chimeric antigen receptor T cells trigger long-term remission of autoimmunity?

Acta Eruditorum ... Dr. Van Voorhees is the physician editor of ... Dermatology World . She interviews the author of a recent study each month. ... By Abby S. Van Voorhees, MD, January 1, 2018 In this month's Acta Eruditorum column, Physician Editor Abby S. Van Voorhees, MD, talks with

January 27, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 27, 2021 ... Can dermatology employers require employees to receive the COVID-19 vaccine? DermWorld Insights and Inquiries : Playing the field — Introducing tirbanibulin for actinic keratosis therapy DermWorld Young

February 21, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 14, 2024 ... Treating keloids, hypertrophic scars with dupilumab DermWorld Insights and Inquiries : Alaskapox — The beat goes on Cosmetic dermatologic procedures performed by physicians vs. non-physicians FDA approves

June 4, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 4, 2025 ... Are nail products safe? DermWorld Insights and Inquiries : High-dose vitamin D may be a ray of sunshine for treating sunburn Fatty acid supplements and atopic dermatitis?

February 18, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 18, 2026 ... Oral finasteride and sexual adverse events DermWorld What’s Hot: Distinguishing persistent nevi from melanoma on histopathology Derm Coding Consult : Coding for surface radiation therapy in dermatology

January 21, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 21, 2026 ... Does finasteride lead to depression, suicide? DermWorld What’s Hot : A tool to modernize, personalize biologic dosing for psoriasis Misdiagnoses of hair, scalp disorders in patients with

March 25, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 25, 2026 ... Finasteride and dutasteride: Depression, suicidal ideation DermWorld What’s Hot: Need for expanded patch testing FDA approves icotrokinra for plaque psoriasis Cutaneous malignancy after biologic therapy Adverse events

July 6, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 6, 2022 ... Long-term recurrence rates of actinic keratoses DermWorld Insights and Inquiries : Isotretinoin and diabetes — Of familiarity and surprise What physicians should know about monkeypox Anti-PD-1 therapy

July 26, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 26, 2023 ... Intralesional HPV vaccine may clear recalcitrant warts DermWorld Insights and Inquiries : Cycling back to doxycycline’s roots as therapy for bullous pemphigoid FDA approves first molluscum contagiosum

June 18, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 18, 2025 ... Incidence of keratinocyte carcinoma with use of acitretin DermWorld Insights and Inquiries : Beef tallow for eczema — Grade A prime or just another bum steer? Academy mourns

July 29, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 29, 2026 ... Risk of cardiovascular disease in dermatology patients taking niacinamide DermWorld What’s Hot: A potential new therapy for dermatomyositis? Is extended dupilumab dosing as effective as standard dosing

October 8, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 8, 2025 ... KOH vs. diclofenac for the treatment of actinic keratosis DermWorld Insights and Inquiries : Injecting ideas (and therapies) in digital mucous cysts FDA approves remibrutinib for chronic

I have questions about coding for contact dermatitis. Does the Academy have any resources to help?

Asked and Answered ... March 1, 2022 Yes. The Academy offers a selection of quick coding guides covering a variety of topics, including contact dermatitis. The Contact Dermatitis Quick Coder has been recently updated to reflect new 2022 codes for irritant contact dermatitis due to contact with body fluids. ...

March 11, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 11, 2020 ... A guide to managing coronavirus in dermatology clinics DW Insights and Inquiries : The 2020 vision for nemolizumab in atopic dermatitis Feedback requested: AAD/NPF draft guidelines for

October 22, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 22, 2025 ... Do dutasteride and finasteride increase mood disorder risk in men with androgenetic alopecia? DermWorld Insights and Inquiries : A potentially effective itsy-bitsy therapy for spider angiomas —

March 24, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 24, 2021 ... Derm Coding Consult : Applying 2021 E/M coding concepts in everyday practice — Part 1 DermWorld Insights and Inquiries : Lipschütz ulcers — Not only for women

February 5, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 5, 2020 ... Legislators aim to prevent sunscreen bans DW Insights and Inquiries : Prurigo pigmentosa as the "keto rash": I’m a believer Correction issued to pediatric psoriasis treatment guidelines

December 10, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 10, 2025 ... Hydrocolloid dressing vs. petroleum for scar appearance after dermatologic surgery DermWorld Insights and Inquiries : The illusions of IgG4-related skin disease Recovering from SJS and TEN Vitamin

April 28, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?

February 25, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 25, 2026 ... Acne relapse after isotretinoin treatment DermWorld What’s Hot: cSCC and adjuvant radiation therapy Where to inject botulinum toxin for ‘bunny lines’ Predictors of drug survival of biologics

May 10, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 10, 2023 ... Is spironolactone use for acne associated with increased risk for venous thromboembolism? DermWorld Insights and Inquiries : PRAME sets its eyes on the road to fame How

Scar solutions

Experts discuss current approaches to scar management. ... Feature ... By Emily Margosian, Assistant Editor, January 1, 2025 Every scar has a story. However, for millions of people worldwide, scars may negatively impact their quality of life, causing psychological distress along with physical discomfort. ... While therapeutic approaches to treat

January 24, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 24, 2024 ... Micrographic vs. conventional excision: Reducing rates of BCC, SCC DermWorld Insights and Inquiries : Senile gluteal dermatosis — The term ‘senile’ is getting old and should be

Social media skin care trends: Dermatologists reveal the facts

Board-certified dermatologists provide tips for healthy skin ROSEMONT, Ill. (Oct. 29, 2024) — With the growing popularity of beauty influencers and viral skin care routines, social media is playing an integral role in shaping how people care for their skin. Popular trends like the glass-skin look, the Russian manicure, and

This month's news from across the specialty

What's hot ... March 1, 2022 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD If we can get ahead of the variants through testing and new treatment regimens, we should be able

May 11, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants

December 20, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 20, 2023 ... Surgical excision vs. 5-FU vs. PDT in treating Bowen’s disease DermWorld Insights and Inquiries : Holiday Greeting 2023 Association between JAK inhibitors and acne Risk of mortality

September 25, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 25, 2024 ... Cyclosporine vs. dupilumab vs. methotrexate for patients with AD DermWorld Insights and Inquiries : The expanding horizon of anti-IL-36 therapy FDA approves new treatment for immune-mediated vasculitis

Seeing eye to eye

Go to AAD Home ... Go to AAD Home ... Menu ... When insurance doesn't cover standard of care treatments, who pays the price and what can be done about it? ... When insurance doesn't cover standard of care treatments, who pays the price and what can be done about

October 23, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein

November

Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... A time for thanks What’s hot ... This month’s news from across the specialty Clinical Applications ... Do tumor-infiltrating lymphocytes predict melanoma outcomes? Feature

A slippery slope

Non-physician providers seek authority to perform cosmetic medical procedures, threatening patient safety and the value of specialty medical training ... Feature ... By Allison Evans, Assistant Managing Editor, May 1, 2022 The Academy has been monitoring and responding to a variety of proposals and bills in the aesthetic arena that

Dermatopathology

Cutting giant congenital nevi down to size molecularly Eosinophilic dermatosis of hematologic malignancy: Reality bites Oy, another "Oid" to worry about: Cryptococcoid lesions Biting my nails worrying about atypical presentations of nail unit melanomas Deep penetrating thoughts about deep penetrating nevi Sophie’s choice: Assessing atypical Spitz tumors in the molecular

January 18, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 18, 2023 ... Have cutaneous manifestations of COVID-19 changed during Delta, Omicron waves? DermWorld Insights and Inquiries : Complications of silicone injections – persistence, stigma, and treatment AAD releases updated

October 26, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 26, 2022 ... Diagnosing and treating onychomycosis DermWorld Insights and Inquiries : Lending a helping hand to our patients with Dupuytren’s disease GoodRx launches provider-facing tool for point-of-care savings Distinguishing

New treatments for HIV and other STIs provide hope for better quality of life

Dermatologist discusses emerging treatments in LGBTQ+ healthcare SAN DIEGO (March 8, 2024) — LGBTQ+ individuals have unique skin care needs, including concerns about sexually transmitted infections (STI), like HIV, as well as acne and hair growth and removal, especially relating to hormone replacement therapy. With over 14 million U.S. adults

August 28, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 28, 2024 ... Is the oral contraceptive pill associated with frontal fibrosing alopecia? DermWorld Insights and Inquiries : Advances in therapy for the Cronkhite-Canada syndrome have increased survival — And

June 12, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 12, 2024 ... Acne in pregnancy: The safest options DermWorld Insights and Inquiries : CXCR4 antagonist therapy based on a WHIM syndrome Nonsteroidal approaches for treating patients with atopic dermatitis

December 11, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 11, 2019 ... Physician depression increases medical errors…increasing depression DW Insights and Inquiries: Topical retinoid therapy for acanthosis nigricans — in the thick of it MIPS: What you need to

July 1, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 1, 2020 ... Derm Coding Consult : E/M coding — What has changed? DW Insights and Inquiries : Spironolactone — An increasingly recognized hero in acne therapy Is it ethical

Harry Nevus: A dermatologist's best friend

In Practice ... Wm. Philip Werschler, MD, FAAD, FAACS, is a dermatologist in private practice in Spokane, Washington. ... By Emily Margosian, May 1, 2018 He’s one “hairy” nevus patients are happy to see. The aptly named Sir Harry Nevus, resident pug and certified therapy animal, is one of Spokane

October 7, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 7, 2020 ... The costs of prior authorizations in a dermatology department DermWorld Insights and Inquiries : Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid

February 26, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 26, 2020 ... Plantar warts: Shave with PDT or cryotherapy? DW Insights and Inquiries : A niche with NICH Legislators seek to expand sunscreen ingredient ban Young Physician Focus :

Pediatric dermatology

Finding Joy in pediatric phototherapy Congenital Juvenile Xanthogranulomas: Born To Be Wild (But Ultimately Mild) Sophie’s choice: Assessing atypical Spitz tumors in the molecular era The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy​ Sirolumus’s merit for the Kasabach-Merritt phenomenon A future therapeutic Harlequin Romance?

Anticoagulants in dermatology

Dermatologists discuss perioperative management of patients on anticoagulant therapy ... Feature ... By Allison Evans, Assistant Managing Editor, June 1, 2022 Writing a script for an anticoagulant is not something dermatologists typically do, although these medications play an important role in clinical and surgical practice. The anticoagulant world has advanced

March 18, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 18, 2020 ... CMS offers physicians flexibility during COVID-19 emergency DW Insights and Inquiries : The profound dermatological manifestations of COVID-19 Feedback requested: AAD/NPF draft guidelines for the management and

What's hot?

What's hot ... March 27, 2018 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... Alopecia areata is frustrating to patients, parents, and practitioners, all of whom may be left with unsatisfactory

Prior authorization’s growing footprint

Facts at your fingertips ... By Emily Margosian, assistant editor, June 1, 2020 While prior authorization requirements have existed since the 1980s, the policy’s impact on physicians, patients, and the larger health care system has evolved considerably over the past four decades. "Physicians expect challenges when prescribing newer specialty drugs,

Medical dermatology

Topical retinoid therapy for acanthosis nigricans: In the thick of it Rituximab and dermatomyositis: Dr. Samitz would be proud The naked truth about total body skin examination: A lesson from Goldilocks and the Three Bears Getting the gist of GIST cutaneous hyperpigmentation disease I never wanted chaperones — until now

Journal of Investigative Dermatology

Cutting giant congenital nevi down to size molecularly I never wanted chaperones — until now An acne vaccine to make patients happy CAMPers? The rosy reality of coffee Aha! The iodide paradox now makes sense! A future therapeutic Harlequin Romance? A string of (clinical) pearls about drug-induced linear IgA disease

September 23, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 23, 2020 ... Nail manifestation and COVID-19: The red half-moon sign DermWorld Insights and Inquiries : The profound dermatologic manifestations of COVID-19: Part VII — Who was that masked man?

Warts and all

Remedies for warts abound, but high-quality studies are lacking. ... Feature ... By Jan Bowers, contributing writer, March 1, 2021 Warts, one of the most common skin disorders worldwide, can be easy to treat or maddeningly difficult. Although warts can resolve spontaneously, others readily respond to over-the-counter treatments such as

This month’s news from across the specialty

What’s hot ... September 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD A novel genetic study that maps mutations in successive stages of cutaneous squamous cell carcinoma (cSCC) in mice

Ergonomics in dermatology

Neck, back, shoulder pain? It could be your exam table. ... Feature ... By Ruth Carol, Contributing Writer, January 1, 2025 After investing an average of 12 years of education and training, the last thing a dermatologist wants is to have their career cut short by musculoskeletal disorders (MSDs). However,

April 20, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 20, 2022 ... Which biologics are most effective for psoriasis? DermWorld Insights and Inquiries : One Toker over the line — Clarifying Toker cell hyperplasia in Zuska disease and its

This month's news from across the specialty

What's hot ... April 1, 2020 In this monthly column, members of  ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty.   ... MALLORY ABATE, MD Interested in some patch testing pearls for your patients with allergic contact dermatitis? In the January issue of ...

January 3, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 3, 2024 ... Efficacy of minoxidil for cancer treatment–induced hair loss DermWorld Insights and Inquiries : Malignant syphilis — History in the making Most effective medications for plaque psoriasis Cardiovascular,

What's hot?

What's hot ... January 2, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Many dermatologists still check baseline labs prior to prescribing oral terbinafine or griseofulvin for adults and children with dermatophyte

Life is just a bowl of cherry angiomas

Learn more about Life is just a bowl of cherry angiomas at aad.org

August 7, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 7, 2024 ... Is oral minoxidil safe for pediatric patients? DermWorld Insights and Inquiries : Rounds on pityriasis rotunda Contact allergens in ‘clean’ children’s products Is cumulative methotrexate associated with

March 13, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 13, 2024 ... Men with androgenetic alopecia may benefit from platelet-rich plasma DermWorld Insights and Inquiries : Coming clean on chlorhexidine-induced dermatoses Roflumilast for the treatment of seborrheic dermatitis Potential

Publishing profiteers

Paper mills sully the integrity of research. ... Feature ... By Andrea Niermeier, Contributing Writer, March 1, 2025 High-impact journals like the ... Journal of the American Academy of Dermatology ( ... JAAD ), ... JAAD Case Reports , ... JAAD Reviews, and ... JAAD International publish pioneering research in

Mogamulizumab for CTCL: Targeted therapy and immunotherapy crossing paths

Read the August 12, 2020 DermWorld Insights and Inquiries on mogamulizumab for CTCL.

Reporting excimer laser therapy: When to use 96999 vs 9692x

As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis.

The expanding horizon of anti-IL-36 therapy

The IL-36/IL-36R axis is crucial in the pathogenesis and treatment of generalized pustular psoriasis. Researchers have demonstrated that this pathway may be instrumental in several other inflammatory dermatoses, as already shown in pyoderma gangrenosum.

Rituximab therapy for recalcitrant dermatitis herpetiformis: A gut feeling

Recently I “accidentally” diagnosed a severely pruritic man with dermatitis herpetiformis (DH). He had seen leading authorities for his life-altering pruritic dermatosis, that clinically and histologically was an eczematous eruption.

The journey of focal dermal hypoplasia: From description to inspired therapy

The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid basal cell carcinoma syndrome (with his good friend

Shades of Shelley: Azithromycin therapy for erythema annulare centrifugum

When I first arrived in Philadelphia in 1984 for my dermatopathology fellowship at the University of Pennsylvania, the most exciting hours of the week were Thursday mornings at the Duhring Conference. Throngs of Delaware Valley dermatologists would attend, listening to the entertaining (and often iconoclastic) pontifications of dermatologic luminaries such

Cycling back to doxycycline’s roots as therapy for bullous pemphigoid

Staphylococcus aureus has the potential to trigger or complicate bullous pemphigoid by infection. Tetracyclines may exert their efficacy via their anti-inflammatory and antimicrobial properties.

CXCR4 antagonist therapy based on a WHIM syndrome

Advances in understanding the pathomechanisms of WHIM syndrome are the prelude to treating this syndrome — and other diseases — with CXCR4 antagonists.

Incretin-based therapy for diabetes and dermatology: Promise and peril

In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes.

Spironolactone: An increasingly recognized hero in acne therapy

Read the July 1, 2020 DermWorld Insights and Inquiries on spironolactone.

The real jigsaw puzzle of the Brooke-Spiegler Syndrome: Translating the molecular biology to therapy

Residents jump for joy when they see the characteristic “jigsaw puzzle” appearance of cylindromas under the microscope. Histopathology, however, takes us only so far.

Naltrexone therapy for Hailey-Hailey disease: Confirming my addiction to evidence-based medicine

I was fascinated by a presentation at the recent World Congress of Pediatric Dermatology discussing improvement of epidermolysis bullosa wounds with topical CBD (cannabis) oil. I asked the presenter how he came up with his hypothesis. He acknowledged that the idea was not his – it came from EB families

Advances in therapy for the Cronkhite-Canada syndrome have increased survival: And that’s the way it is

Early recognition and treatment of the Cronkhite-Canada syndrome may significantly improve the prognosis of this potentially lethal disease.

Expanding your cosmetic services

In Practice ... Beth Santmyire-Rosenberger, MD, PhD, is the owner of Appalachian Spring Dermatology, PLLC, in Fairmont, West Virginia. ... By Victoria Houghton, managing editor, May 1, 2019 Dermatology World talks with Beth Santmyire-Rosenberger, MD, PhD, from Appalachian Spring Dermatology, PLLC, in Fairmont, West Virginia, about how to expand the

Laser focus

Dermatologist experts discuss the latest advances in laser technology and offer tips on how to navigate the research and acquisition process ... Feature ... By Allison Evans, assistant managing editor, April 1, 2021 For the new dermatologist moving from residency to practice, or the established dermatologist simply seeking a challenge,

Shocking news: Heat shock protein inhibition finally enters the realm of dermatologic therapy

Heat shock protein inhibition is a novel approach that may prove valuable for dermatologists treating inflammatory, autoimmune, bullous, and oncologic diseases.

From "slugging" to snail mucin

Dermatologists discuss popular social media trends impacting the skin. ... Feature ... By Emily Margosian, Assistant Editor, October 1, 2023 Social media and the skin have a long history together. For over 15 years, social media has been an ever-growing presence in nearly all facets of life: politics, commerce —

Cannabinoids may elevate therapy for connective tissue diseases to a higher level

Medical “reefer madness” is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of medical cannabis. (1)

We’ve got new AK guidelines with CME credit

The AAD recently released guidelines of care for the management of actinic keratosis (AK).

Deciding the right time for treatment

Experts discuss neoadjuvant vs. adjuvant immunotherapy for melanoma — and recent advances in the neoadjuvant space. ... Feature ... By Emily Margosian, Assistant Editor, May 1, 2025 "The melanoma landscape, especially in the last decade or so, has changed remarkably in ways I never thought I would see in my

PDT for erosive pustular dermatitis of the scalp: Seeing the light (but reaching a different conclusion)

Erosive Pustular Dermatitis of the Scalp (EPDS) is a relative common condition, typically seen on the actinically damaged scalps of the elderly men. Lesions characteristically present as hyperkeratotic, crusted erosions with varying degrees of pustulation. Lesions may become secondarily infected.

Checking in on the adverse reactions to checkpoint inhibitors

Earlier this year there have been two posts devoted to adverse reactions of checkpoint inhibitors (“Thinking of Discontinuing the PD-1 Inhibitor Because of a Lichenoid Eruption? Don’t do it!” published on May 21st and “Joining the Bullae Pulpit: PD-1 inhibitors” posted on August 25th). Do further studies corroborate these studies?

Vitiligo and melanoma: New thoughts on an old observation

I was fortunate that as a resident and fellow I had marvelous attending physicians who would offer their pearls of wisdom. As it is impossible to study every dictum, I would (usually) accept these viewpoints as “facts” and incorporate them into practice. An example is performing a full skin examination

Managing formulary changes

DermWorld looks at disruptive prescription coverage changes and offers tools for navigating these pain points. ... Feature ... By Amy Freed Stalzer, Contributing Writer, March 1, 2023 It’s not an uncommon scenario: A dermatologist refills a prescription for a patient but comes to find out that the patient’s insurance formulary

I never wanted chaperones — until now

Learn more about I never wanted chaperones — until now at aad.org

Lagging ahead: LAG-3 checkpoint inhibition for advanced melanoma

Read the May 11, 2022 DermWorld Insights and Inquiries on LAG-3 checkpoint inhibition for advanced melanoma.

Calcipotriene and 5-fluorouracil: Dermatology’s new dynamic duo?

Learn more about Calcipotriene and 5-fluorouracil: Dermatology’s new dynamic duo? at aad.org

Beyond dermoscopy

Emergent technologies enhance imaging, target rare diseases. ... Feature ... By Jan Bowers, Contributing Writer, August 1, 2023 Dermoscopy has arrived. "While there are established practicing dermatologists who are not using it, it’s integrated across the residency programs," said Ashfaq A. Marghoob, MD, FAAD, attending physician at Memorial Sloan Kettering

A plasma cell dyscrasia fable: AESOP and POEMS presenting concurrently

There is a moral to every fable. In this commentary, it is that VEGF (vascular endothelial growth factor) may have multiple cutaneous manifestations, even in the same patient.

Can oral ivermectin cure pediatric periorificial dermatitis? It mite!

Ask any child when how long it is until their next birthday and they can usually give you a precise answer. If I’m treating a child with periorificial dermatitis (POD, also granulomatous POD or perioral dermatitis), I can’t wait until they turn 8, so I can prescribe doxycycline.

Adherence to acne treatments: Flipped sides of the coin for physicians and patients

It takes a motivated, dedicated patient to adhere to their prescribed acne regimen. According to Moradi Tuchayi et al, primary nonadherence occurs when the medication is not even started.

2026 CPT coding updates

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, January 1, 2026 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The Centers for Disease Control and Prevention

Guidance on the use of immunosuppressive agents

Access Academy information on treating patients with immunosuppressive agents during the COVID-19 pandemic. The Academy urges patients not to discontinue such treatment without first consulting with their physicians. The Academy offers interim guidance on using immunosuppressive agents.

Navigating drug shortages and more: Strategies and solutions

Answers in Practice ... By Olivia Barry, Manager, Practice Management, February 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff explains how to navigate drugs shortages and more. Prescription drug shortages are a persistent and complex challenge across dermatology. What is the

Perspectives on peristomal pyoderma gangrenosum

Peristomal pyoderma gangrenosum (PPG) is a challenging problem, both physically and emotionally. The diagnosis may be delayed, often being mistaken for an irritant dermatitis or an infection.

Actinic keratosis guideline

Access information on the Academy's guidelines of care for actinic keratosis. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

Shedding light on tumoral melanosis

The rare phenomenon of tumoral melanosis may become more common with advances in melanoma immunotherapy. Such cases may have a better prognosis than cases of TM due to regression from advanced disease.

Advocacy Update Jul 22, 2025

The AADA submitted nomination materials recommending AADA Dermatopathology Committee Chair Alina Bridges, DO, FAAD, for membership on the CDC’s Advisory Committee to the Director.

Advocacy Update June 30, 2026

AADA President Murad Alam, MD, MSCI, MBA, FAAD, met with federal legislators on Medicare physician payment reform in Washington, DC.

Advocacy Update June 2, 2026

The House Ways and Means Committee unanimously passed H.R. 8163, the Provider Reimbursement Stability Act, which would reform budget neutrality policy in Medicare physician payment.

March 7

Learn more about March 7 at aad.org

What is the role of dietary fiber and probiotics on the microbiome and melanoma immunotherapy response?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, July 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Kelly Nelson, MD,

August 30, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 30, 2023 ... Does low-dose oral minoxidil improve hair density in traction alopecia? DermWorld Insights and Inquiries : A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma Methotrexate: Drug survival and predicative

February 5, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / February 5, 2025 ... PRP, microneedling, and topical minoxidil for refractory severe androgenetic alopecia DermWorld Insights and Inquiries : Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and

September 11, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 11, 2024 ... Safety of low-dose oral minoxidil for hair loss in patients receiving antihypertensive medications DermWorld Insights and Inquiries : Atopic dermatitis hide and seek — The impending role

July 8, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 8, 2026 ... Potassium monitoring in older females taking spironolactone DermWorld What’s Hot: Preoperative antibiotic prophylaxis and penicillin allergy Topical vs. systemic corticosteroids for DRESS syndrome Which JAK inhibitor shows

Moving target

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists have good options for treating actinic keratosis, but price fluctuations make picking the highest value option difficult ... Dermatologists have good options for treating actinic keratosis, but price fluctuations make picking the highest value option difficult ...

Chipping away at patient access hurdles

From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, February 1, 2019 Picture this: A sick patient comes in for your help. As an experienced dermatologist, you know exactly what to do and are confident your prescribed course

Cutting giant congenital nevi down to size molecularly

Learn more about Cutting giant congenital nevi down to size molecularly at aad.org

What's hot?

What's hot ... December 30, 2017 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Annie Chiu, MD ... Body contouring is not only in demand among patients but presents a unique challenge for physicians to achieve consistent

Can topical ketoconazole tip the scales for acne vulgaris?

Read the October 21, 2020 DermWorld Insights and Inquiries on topical ketoconazole and acne vulgaris.

Advocating for you — Highlighting the specialty in the nation’s capital

The messages you delivered to members of Congress in 200+ virtual meetings did not go unnoticed, and had a direct impact on legislation that affects you and your patients.

Scarred by dogma: Revising recommendations for surgery and isotretinoin use

I have had the privilege of prescribing isotretinoin since its release in 1982. Is there any other dermatologic medication that has benefited our patients so greatly?

March is a strange month

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, March 1, 2021 Other than the AAD Annual meeting (sadly, canceled for the second year, courtesy of the ongoing COVID-19 pandemic), there’s usually not much to look forward to in March. Sure,

November 1, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 1, 2023 ... Can oral nutraceuticals reduce isotretinoin side effects? DermWorld Insights and Inquiries : Exchanging plasma exchange for a novel approach — The potential of FcRn antagonists in dermatologic

Keeping abreast of drug-induced cutaneous lupus

Read the August 4, 2021 DermWorld Insights and Inquiries on drug-induced cutaneous lupus.

March 17, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 17, 2021 ... COVID-19 in melanoma patients DermWorld Insights and Inquiries : Hoops and happiness — Having the courage to take a shot DermWorld Young Physician Focus : Forging ahead

Impact Report — Spring 2021

In this edition we’ll update the top-level items that affect you and improve your practice in several areas including advocacy for you, our public efforts, and our member benefits.

Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18

Access reporting information for QCDR measure AAD 18: Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection. Review the maximum points available, the measure type, measure specifications, and much more.

Problematic in pregnancy?

Dermatologists discuss the safety of common dermatologic drugs in pregnant patients. ... Feature ... By Jan Bowers, Contributing Writer, June 1, 2023 Few mourned the end of the FDA’s pregnancy risk letter categories for prescription and biologic drug labeling in 2015. In addition to being an oversimplified distillation of available

Vaccines, maintenance, and PEP

Learn about vaccine status based on birth year and high-risk individuals who should have vaccine boosters. Also, see our resources on post-exposure prophylaxis (PEP) and administering immunoglobulin.

Sirolumus’s merit for the Kasabach-Merritt phenomenon

We wish to report the following case of an extensive hemangioma of the skin associated with diffuse purpuric manifestations. The course and management of the condition, we believe, are of unusual interest.

Treating metastatic melanoma: Understanding a brave new world

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel

Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?

Read the February 12, 2020 DermWorld Insight and Inquiries on treating lentigo maligna.

A checkup on immune checkpoint inhibitor-induced subacute cutaneous lupus

Read the March 15, 2023 DermWorld Insights and Inquiries on immune checkpoint inhibitor-induced subacute cutaneous lupus.

An appealing step closer to targeted topical therapies

Read the April 5, 2023 DermWorld Insights and Inquiries on an appealing step closer to targeted topical therapies.

American Academy of Dermatology issues first-ever pediatric atopic dermatitis guidelines, highlighting prevention strategies and effective treatments

New evidence-based guidelines establish insufficient evidence or no benefit to dietary or environmental interventions ROSEMONT, Ill. (April 7, 2026) — For the first time in its history, the ... American Academy of Dermatology (AAD) has published guidelines of care for both the ... prevention and ... management of atopic dermatitis

New data to recall when considering radiation recall dermatitis

Read the September 30, 2020 DermWorld Insights and Inquiries on radiation recall dermatitis.

Vitiligo or vitiligo-like lesions and PD1-inhibitors: Which is right?

No one will dispute that depigmented lesions occur in melanoma patients treated with PD-1 inhibitors. What is debatable is whether these lesions are vitiligo or vitiligo-like lesions.

Applying the 2021 E/M coding concepts in everyday practice – Part 2

The introduction of the revised 2021 evaluation and management (E/M) coding guidelines has generated a plethora of questions from dermatologists in the application of the concepts used in the medical-decision making table (MDM). To help members navigate the E/M changes in a simplified and relatable manner in everyday practice, the

April 1, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 1, 2026 ... Aesthetic treatment considerations for perimenopausal, menopausal patients DermWorld Insights and Inquiries : Cocaine-associated plasma cell orificial mucositis — Anything goes Effects of PRP, minoxidil in patients with

Advocacy Update Aug 12, 2025

The AADA asked congressional leadership to support the SAFE Sunscreen Standards Act by including it in the reauthorization of the Over-the-Counter Monograph Drug User Fee Program.

Links in the care chain

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... By Jan Bowers, contributing writer A diagnosis of advanced melanoma marks the

Applying the 2021 E/M coding concepts in everyday practice – Part 8

Part eight of the Academy's clinical vignettes focuses on the application of coding concepts related to E/M encounters.

Oncolytic virotherapy and the dermatologist

My late British cousin Tim, a brilliant, kind, benevolent husband, father, gastroenterologist, and MBA, lost his battle with glioblastoma in 2016 at age 55.* I was hoping that he might be able to get into a trial using an oncolytic virus (OV), but that was not possible.

Academy secures wins with private payers

The Academy works with private payers to alleviate administrative burdens for dermatologists, maintain appropriate reimbursement for furnished services, and ensure patients can access covered quality care.

Treatments for renal IgA vasculitis are beginning to flow

Renal disease is the most severe complication of IgA vasculitis. New treatments such as iptacopan (an alternative complement inhibitor) and atrasentan (an endothelin type A receptor inhibitor) are promising novel therapies for this challenging disease.

Optimizing melasma management

Experts discuss treatment strategy, new insights into pathogenesis, and emerging therapies. ... Feature ... By Emily Margosian, Senior Editor, March 1, 2026 Pigmentary disorders represent some of the most common cutaneous concerns globally. In the U.S. alone, melasma affects more than 5 million people (doi:10.1016/j.jaad.2010.12.046). ... While primarily a cosmetic

2024 DW Insights and Inquiries archive

Explore past issues of DW Insights and Inquiries that were published in 2024.

March 18, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 18, 2026 ... Oral hyaluronic acid supplement: Does it improve skin aging? DermWorld What’s Hot: Insurance denial of ‘cosmetic’ conditions Is topical urea beneficial for onychomycosis? Does the application of

Cutaneous Squamous Cell Carcinoma

Access the Academy's clinical guidelines on cutaneous squamous cell carcinoma. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

Basal cell carcinoma clinical guideline

Read the Academy's clinical guidelines on basal cell carcinoma. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

Seeing red with dupilumab

Read the March 1, 2023 DermWorld Insights and Inquiries on seeing red with dupilumab.

Yeast rising: Predicting the efficacy of candida antigen immunotherapy for warts

Perhaps I’m paranoid, but I always think that warts are laughing at me, or at least at whatever I throw at them — cryosurgery, curettage, electrosurgery, laser, salicylic acid, cantharadin, squaric acid dibutyl ester, 5 fluorouracil, imiquimod, podophylloltoxin, sinecatechins, or cidofovir. I think the wart has a grand time scheduling

August 21

Learn more about August 21 at aad.org

September 15, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 15, 2021 ... Worsening psoriasis after COVID-19 vaccination DermWorld Insights and Inquiries : Is ivermectin an old drug with new tricks? Frontal fibrosing alopecia and facial care products Biden administration

Should merkel cell carcinoma patients receive adjuvant radiation following excision? My personal parallel story

I was 34 years old when I was diagnosed with a stage I seminoma. Following an orchiectomy, I was instructed to see the radiation oncologist (at the same institution) for adjuvant radiation.

Toxicity of topical timolol for infantile hemangiomas in preterm infants: Size matters

I have been using topical timolol (0.5% gel) for the past few years for infants with infantile hemangiomas (IH) with reasonable success, but I am always nervous about prescribing it, as data on the degree of topical absorption remains to be defined.

Progress in pemphigus: Solidifying rituximab’s role

Read the July 7, 2021 DermWorld Insights and Inquiries on solidifying rituximab’s role in pemphigus treatment.

Granulomatous cheilitis: Back to the Future

Read the June 1, 2022 DermWorld Insights and Inquiries on granulomatous cheilitis.

My fair-weather therapeutic friends for alopecia areata

We were never best of friends, but we got along well most of the time. The relationship seemed to work, with rare moments of ecstasy, but was irritating all too often. There were no major conflagrations; we just drifted apart.

May 1, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 1, 2024 ... Consensus statements for the treatment of vitiligo in younger patients DermWorld Insights and Inquiries : Eyebrow-raising complications of microblading Role of low-dose oral minoxidil for treatment of

October 25, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 25, 2023 ... Efficacy of berdazimer gel for molluscum contagiosum clearance DermWorld Insights and Inquiries : A permanent addition to the list of transient neonatal dermatoses — Transient abdominal telangiectasia

June 26

Learn more about June 26 at aad.org

July 23, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 23, 2025 ... How to recognize a difficult squamous cell carcinoma DermWorld Insights and Inquiries : Sebaceous carcinoma — Double trouble Exploring novel therapies for acne scar treatment Survival after

Advocacy Update March 3, 2026

The AADA has actively engaged CMS around training requirements for dermatologists performing SRT.

June 17, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 17, 2026 ... P ractical recommendations for seborrheic dermatitis: An expert consensus DermWorld What’s Hot: Rituximab and concurrent IVIG treatment What therapies show best long-term effectiveness for psoriasis? Long-term efficacy,

Taking biologics to heart

Comorbidities related to psoriasis have dominated the dermatologic literature for more than a decade since Joel Gelfand published his seminal paper.

Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best

My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting – they want a specific diagnosis for one reason only – to get the right treatment, preferably curative.

Sky high

PBM tactics increase drug prices, lower patient access ... Feature ... By Ruth Carol, Contributing Writer, September 1, 2022 Last month, ... DermWorld discussed the role pharmacy benefits managers (PBMs) play in the drug distribution chain. This month, we will discuss some of the tactics PBMs use that are driving

Weighing the options

As biologic therapies expand indications to children and adolescents, what do dermatologists need to know about balancing the risks and benefits? ... Feature ... By Allison Evans, Assistant Managing Editor, February 1, 2023 Over the past five years, younger patients have steadily gained access to a range of FDA-approved targeted

Preventing and treating Trichophyton indotineae

Because confirmatory testing may take weeks, it is reasonable to empirically start treatment for T. indotineae based on patient epidemiologic and clinical features while awaiting confirmatory testing. Potassium hydroxide (KOH) preparation of skin scrapings should be performed in clinic, whenever possible, to confirm fungal infections.

April 26, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 26, 2023 ... Paroxetine for refractory erythema of rosacea? DermWorld Insights and Inquiries : Demodectic eruptions — More than you mite have imagined Nonthermal atmospheric plasma for molluscum and verruca

An incisive approach to chronic paronychia: The square flap technique

I cannot begin to guess how many patients I have seen with chronic paronychia (CP) since I started my residency 36 years ago. I know precisely how many patients I have referred for surgical correction of CP – zero! The reason for that is that I never thought about this

In the Know

The AMA and UHC Collaborate to Develop Social Determinant Diagnosis Codes ... Did you know that United Healthcare (UHC) and the American Medical Association (AMA) are proposing to develop 23 new ICD-10-CM diagnosis codes that address social barriers to care? ... Developed by UHC and endorsed by the AMA, they

September 24, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 24, 2025 ... Is red light PDT with ALA effective for the treatment of BCC? DermWorld Insights and Inquiries : The 21st Century Cures Act — What a difference a

Memories of pneumocystis pneumonia and thoughts of prophylaxis

My childhood friend Alan was a rotating surgical resident at Methodist Hospital in Houston when he saw my brother Andrew in the ICU. “Warren, I think you better come here ASAP.” Thirty-six years ago, the first sight of my severely jaundiced brother, with nasal necrosis (presumably mucormycosis), and a chest

Epidermolysis bullosa: The need for novel topical care

The advances in epidermolysis bullosa (EB) have been spellbinding.

JAKne is on the horizon

Read the July 27, 2022 DermWorld Insights and Inquiries on JAK and acne.

Develop a nose for suspecting angiosarcoma

Could that dermatofibroma have been a desmoplatic melanoma? Add a new reason for histopathologic insomnia – “deceptively bland” angiosarcomas (AS) mimicking hemangiomas.

The ultimate prognosis of eosinophilic fasciitis may not be groovy

My patients with eosinophilic fasciitis (EF, Shulman syndrome) have been fortunate. They have been “classic” cases with mostly upper extremity lesions, precipitated by exercise, and have responded to corticosteroids. My sanguine impression of EF has been tempered by recent literature – it may not be so benign.

September 8, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 8, 2021 ... A review of spironolactone for androgenetic alopecia DermWorld Insights and Inquiries : Alarming but benign – The enigma of acute hemorrhagic edema of infancy What are the

August 27, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 27, 2025 ... A tool to assess patients at high-risk for cutaneous squamous cell carcinoma DermWorld Insights and Inquiries : Chanarin-Dorfman syndrome — Shifting out of neutral Carbon dioxide laser

Advocacy Update Oct 28, 2025

After weeks of confusion, CMS allowed MACs to begin processing most claims with dates of service on or after Oct. 1, 2025.

Advocacy Update Jun 3, 2025

The AADA continues discussions with CMS advocating for revisions to recent CLIA requirements to ensure that all board-certified dermatologists are approved as lab directors of dermatology labs.

Find drug prices in your area

Use free online resources that help patients find prescription savings.

Cutaneous complications of immune checkpoint inhibitors

DermWorld highlights some of the common (and not-so-common) skin complications associated with ICIs and shares expert tips for management. ... Feature ... By Heidi Splete, Contributing Writer, March 1, 2024 Immune checkpoint inhibitors (ICIs) are a mainstay of immunotherapy for many cancer types — including breast, colon, liver, lung, skin,

Tailor-made care

Go to AAD Home ... Go to AAD Home ... Menu ... Experts discuss the benefits of personalized treatment plans for patients with hidradenitis suppurativa ... Experts discuss the benefits of personalized treatment plans for patients with hidradenitis suppurativa ... By Jan Bowers, contributing writer Hidradenitis suppurativa (HS) was once

No longer flailing with Flegel disease

Read the April 19, 2023 DermWorld Insights and Inquiries on Flegel disease.

Isotretinoin and diabetes: Of familiarity and surprise

Read the July 6, 2022 DermWorld Insights and Inquiries on isotretinoin and diabetes.

AAD’s Your Dermatologist Knows maintains strong traditional media presence

Traditional media relations, targeting print, broadcast, and online media, are a cornerstone of the AAD’s successful Your Dermatologist Knows consumer positioning strategy, and 2025 was an exceptional year for those efforts.

AAD Prior Authorization Appeal Letter Tool

Streamline appeals for over 50 dermatology drugs with our letter tool. Create customizable letters with medical rationales and references written by AAD members. Please note that personal information entered into the prior authorization tool is not saved by the AAD nor shared with any entity.

Derm Coding Consult

Access the latest edition and past issues of the AAD's Derm Coding Consult. Derm Coding Consult provides Academy members with the latest information about accurate diagnostic and procedural coding, as well as Medicare reimbursement issues in dermatology.

Does he or doesn’t he? Only his oncologist knows for sure!

By Warren R. Heymann, MD July 17, 2017 Repigmented hair overlying melanoma in situ of scalp. Slowly darkening patch of previously white hair on superior scalp. ... Credit: ... JAAD I’m racking my brain wondering if I have ever seen a case of idiopathic facial aseptic granuloma (IFAG) — I

Putting muscle into isotretinoin laboratory testing isn’t chopped liver!

Learn more about Putting muscle into isotretinoin laboratory testing isn’t chopped liver! at aad.org

April 3

Learn more about April 3 at aad.org

Progress for progressive multifocal leukoencephalopathy

Learn more about Progress for progressive multifocal leukoencephalopathy at aad.org

Further dermatologic observations in cystic fibrosis

The Cystic Fibrosis Dermatitis Arthritis Syndrome should be suspected in young (mostly female) cystic fibrosis patients presenting with episodic arthritis and rash.

Can tocilizumab deep six recalcitrant morphea?

The IL-6 inhibitor tocilizumab may have a therapeutic role in cases of recalcitrant morphea.

Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double

Case reports and retrospective studies have demonstrated dupilumab’s efficacy in treating bullous pemphigoid. Preliminary data from a prospective trial confirms dupilumab’s therapeutic value. Perhaps approval of dupilumab for bullous pemphigoid is on the horizon.

Springtime is tick time

Oh, the majesty of spring’s rejuvenation – a bloom’s aroma, opening day’s first pitch, and romance in the air. For dermatologists, no one will write a sonnet devoted to rhus dermatitis, polymorphous light eruption or Rocky Mountain Spotted Fever (RMSF)!

OblIgEd to search for steroid-sparing agents in treating bullous pemphigoid

I’m always anxious to learn about alternative approaches for treating bullous pemphigoid (BP).

September 10, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 10, 2025 ... Most effective monotherapy for androgenetic alopecia DermWorld Insights and Inquiries : Twenty-first century pellagra Is there an association between JAKis and malignancy risk in alopecia areata? PRP

Erosive pustular dermatosis of the scalp must no longer be dermatology’s secret

As dermatologists, we get used to discussing disorders that are foreign to other physicians. A typical story would be someone with classic notalgia paresthetica whose primary care physician does not believe that cervical arthritis is responsible for the maddening scapular pruritus. “My doctor never heard of such a thing!” patients

Increasing evidence for the use of topical timolol for pyogenic granulomas

There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion.

2020 DW Insights and Inquiries archive

Explore past issues of DW Insights and Inquiries that were published in 2020.

July 31

Learn more about July 31 at aad.org

May 29

Learn more about May 29 at aad.org

Other emerging severe and resistant dermatophytes of concern

Other emerging dermatophytes of concern include Trichophyton rubrum and Trichophyton mentagrophytes type VII. Learn about treatment and patient counseling.

Shedding light on treatments for female pattern hair loss

Dermatologist hair experts discuss the efficacy and safety considerations of off-label treatments for female pattern hair loss. ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2025 A female patient presents with thinning hair and a reduction in hair density at the top of the scalp. Is it

2025 quality measures for MIPS reporting

Learn about 2025 quality measures for MIPS reporting. This page provides access to all dermatology-specific measures that can be reported for MIPS. Select the measure number to access a full page of analysis, documentation tips, FAQs, and more.

Psoriasis clinical guideline

Access information on the Academy's guidelines of care for psoriasis. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

June 25, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 25, 2025 ... Safety of low-dose oral minoxidil in older patients DermWorld Insights and Inquiries : Metastatic uveal melanoma — Tebentafusp unobfuscated New focused atopic dermatitis guidelines update available FDA

The neutrophil-to-lymphocyte ratio in cancer: Beauty in simplicity

The world was stunned and saddened on January 28th, 1986 when the Space Shuttle Challenger exploded. Six months later, during the meeting of the Rogers Commission analyzing the disaster, the famed physicist Richard Feynman demonstrated how O-rings lost their resilience. By placing the sample material in ice water, he proved

Dyeing for a “new” topical agent for psoriasis? Think indigo

Despite the magnificent revolution of biologics for psoriasis, topical agents remain the cornerstone of treatment, either alone, or in combination with phototherapy or systemic treatments.

May 6, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 6, 2026 ... Nutritional, light-based, and lifestyle interventions for androgenetic alopecia DermWorld Insights and Inquiries : Granular C3 dermatosis in granular detail Risk of infection with JAK inhibitors Oral vs.

August 6, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 6, 2025 ... Minoxidil, finasteride, dutasteride monotherapy for male pattern hair loss DermWorld Insights and Inquiries : Further dermatologic observations in cystic fibrosis DermWorld Insights and Inquiries — Another Viewpoint:

Applying the 2021 E/M coding concepts in everyday practice – Part 7

Part seven of the Academy's clinical vignettes focuses on the application of coding concepts related to E/M encounters.

Tofacitinib: A JAK inhibitor of all trades

Learn more about Tofacitinib: A JAK inhibitor of all trades at aad.org

What we have learned about E/M coding and reimbursement in 2021

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding & reimbursement, April 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . On Jan. 1, 2021, changes were implemented to

Stepping back from the abyss: A kinder, gentler variant of calciphylaxis

My reaction to the diagnosis of calciphylaxis is Pavlovian – I automatically think about an end-stage renal insufficiency patient with an abysmal prognosis. Increasingly there are reports of nonuremic forms of the disease, where the prognosis may not be as bleak (*although clinically very significant).

Becoming whipped up over flagellate dermatoses

The literature on flagellate dermatoses has been whipped into frenzy.

Advocacy Update Apr. 1, 2025

HHS announced a major restructuring to reduce full-time employees, consolidate divisions, and decrease regional offices.

What’s new in treating actinic keratosis?

Dermatologists discuss how to balance the latest evidence, patient preferences, and clinical experience when treating AKs ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2022 Actinic keratoses (AKs) are commonly diagnosed and treated by dermatologists. In fact, the National Ambulatory Medical Care Survey on outpatient medical care

Turning our attention to melanoma risk in Turner syndrome

Patients with Turner syndrome have an increased risk of melanoma, possibly related to the number of nevi. The use of human growth hormone may contribute to the appearance of a larger number of acquired melanocytic nevi. Patients with Turner syndrome should be routinely screened for melanoma and practice standard sun

Academy HAIR Grants take off

AAD distributes another round of hair disorder research grants ... Feature ... By Matthew Walsh, Member Communications Specialist, October 1, 2022 Earlier this year, the AAD awarded seven Hair Loss and Alopecia Initiative in Research (HAIR) grants to dermatologists across the country to help fund their research of hair disorders

Raising a toast to advances in treating alcohol-induced flushing

Read the November 11, 2020 DermWorld Insights and Inquiries on advances in treating alcohol-induced flushing

Sweating over acquired idiopathic generalized anhidrosis

Read the June 8, 2022 DermWorld Insights and Inquiries on acquired idiopathic generalized anhidrosis.

March 20, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 20, 2024 ... Combination imiquimod and 5-FU for treating AKs DermWorld Insights and Inquiries : San Diego AAD musings Talking points: Benzene found in acne care products Safety of dermatologic

Do tumor-infiltrating lymphocytes predict melanoma outcomes?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, November 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with John T. Vetto,

PD1 blockade: The next step for aggressive basal cell carcinomas?

I was about to start the weekend, relishing that delightful TGIF feeling, with one final task – go through lab reports in my bin. My mood became morose when I read the follow-up letter about Sue (not her real name). She is a lovely woman in her 40’s who did

July 29, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 29, 2020 ... COVID-19: The impact on employed dermatologists DW Insights and Inquiries: The profound dermatological manifestations of COVID-19 part VI — Going to the dogs Young Physician Focus :

January 7, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 07, 2026 ... Is beef tallow effective for dermatologic conditions? DermWorld Insights and Inquiries : Cannabis arteritis — Getting higher on the differential diagnosis list of ulcerative lesions GLP-1s in

October 15, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 15, 2025 ... Do new psoriasis biologics have better safety profiles than adalimumab? DermWorld Insights and Inquiries : Erectile dysfunction in dermatology — A silent epidemic AAD seeks member comments

Atopic dermatitis clinical guideline

Access information on the Academy's guidelines of care for atopic dermatitis. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

This month’s news from across the specialty

What’s hot ... December 1, 2025 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Craig Burkhart, MD, MPH, MSBS, FAAD New parents are participating in a new "nutty" trend where they give healthy infants their first taste of

Sirolimus for microcystic lymphatic malformations: Caviar for frog spawn

Recently, our understanding of lymphatic malformations (LMs) has vastly expanded. Genetic advances have focused on the PI3K/AKT/mTOR pathway allowing the use of mTOR inhibitors for those lesions involved in this pathway.

Tofacitinib for adolescent alopecia areata: Balancing the risk-benefit ratio

There has been acute interest in utilizing Janus kinase (JAK) inhibitors for alopecia areata (AA). Does the media’s fervor touting tofactinib’s success translate into a rational decision to prescribe it for young patients?

Changing a long-standing habit

Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK).

Impact Report — Fall 2021

The Impact Report looks at the big picture of the Academy. See how we support you through advocacy, read about our success in positioning your expertise with the public, and learn more about the important benefits your membership offers you.

Avascular necrosis in psoriasis: Avoiding “snap” judgments

Of all the adverse reactions of corticosteroids, there is none more terrifying than avascular necrosis (AVN, aka osteonecrosis); this usually involves the femoral head (AVN of the hip), although the shoulders and knees may be affected.

A future therapeutic Harlequin Romance?

My fiancé Ronnie, then a pediatric resident, called me excitedly, asking for my opinion about a remarkable neonate that was just delivered at Elmhurst Hospital. I was at our dermatology resident clinic in Van Etten Hospital, and recited her description of a newborn (large plates of creamy brown scale, fissures,

Prior authorization audits and innovations: Are we finally reducing the (PA)in?

Much data supports the inefficiency and poor clinical outcomes related to impractical prior authorization (PA) implementation. There are numerous resources, including your own office/department (e.g., hiring a clinical pharmacist) and state (e.g., local medical societies) and federal (e.g., AMA) organizations to provide frameworks and enact laws to reduce the administrative

This month’s news from across the specialty

What’s hot ... January 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Jason Lee, MD, FAAD The incidence of melanoma in situ (MIS) has risen sharply in the U.S., surpassing invasive melanoma in 2025 ( ...

Move over Lues: Graft-versus-host disease is the new mimicker king

I have always been intrigued by graft-versus-host disease (GVH). I first learned of the disorder in my college immunology course when it was referred to as a cause of “runting syndrome” in mice.

Thinking of discontinuing the PD-1 inhibitor because of a lichenoid eruption? Don’t do it!

Immune checkpoint inhibitors have been the proverbial “game changers” in oncology, and offer hope (and a chance of survival) where none existed just a few years ago.

Technology-based encounters in dermatology

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, August 1, 2019 Test your knowledge: Technology-based encounters in dermatology ... Take the quiz to see if you're up

Decomplexing plexiform neurofibromas

Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome.

The power of state advocacy

From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, November 1, 2019 When you think of advocacy, what do you think of? Capitol Hill and Congress? CMS and the FDA? If so, you’re not wrong. Many facets

Advocacy Update Feb 10, 2026

The AADA, in collaboration with the allergy specialty societies, demanded that the FDA preserve patient access to high-quality patch testing haptens.

Notes from Washington

Watch updates from AADA President Murad Alam, MD, MSCI, MBA, FAAD, on Medicare physician payment reform and more.

The pregnant pause in cutaneous lymphoma

Cutaneous T-cell lymphoma during pregnancy presents unique challenges in preventing disease progression and maintaining fetal viability. Many standard therapies used in the non-gravid state are contraindicated; topical steroids, phototherapy, and interferon are considered safe options. A multidisciplinary approach is necessary for optimal management.

Managing melasma

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists discuss new understandings of the pathogenesis of melasma and emerging treatments ... Dermatologists discuss new understandings of the pathogenesis of melasma and emerging treatments ... By Jan Bowers, contributing writer The emotional toll of melasma on patients

Probing pediatric pigmented purpuras

Read the October 20, 2021 DermWorld Insights and Inquiries on pediatric pigmented purpuras.

Early recognition of Rituximab-induced late onset neutropenia is essential

Read the April 13, 2022 DermWorld Insights and Inquiries on early recognition of Rituximab-induced late onset neutropenia.

December 6, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 6, 2023 ... iPLEDGE wins: FDA to implement AADA’s recommendations DermWorld Insights and Inquiries : Aquagenic pruritus and polycythemia vera: Still valid (and mysterious) after all these years Treatment access

What do the AAD's new non melanoma skin cancer guidelines say?

Acta Eruditorum ... Dr. Van Voorhees is the physician editor of ... Dermatology World . She interviews the author of a recent study each month. ... By Abby S. Van Voorhees, MD, February 1, 2018 In this month's Acta Eruditorum column, Physician Editor Abby S. Van Voorhees, MD, talks with

Cosmetic treatments

By communicating these key messages on cosmetic treatments, you can help position the specialty while increasing your credibility and raising the profile of your practice. Review key messages tailored to the different kinds of cosmetic treatments, including fillers, botulinum treatment, liposuction, and more.

Psoriatic alopecia and sebaceous glands: An unfinished symphony

Every so often, patients with psoriasis would ask me about their hair loss, and I assumed that it was mechanical in nature, probably due to breakage of hair getting tangled in scales, and traumatized by pruritus.

August 20, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 20, 2025 ... Oral vs. topical finasteride: Sexual, neuropsychiatric AEs DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma Are topical

Is low-dose methotrexate associated with a higher risk of melanoma development?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, February 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Anita Wluka, PhD,

Finding Joy in pediatric phototherapy

Learn more about Finding Joy in pediatric phototherapy at aad.org

Advocacy Update Apr. 29, 2025

The AADA urges CMS to address No Surprises Act burden requirements.

JAAD

Putting muscle into isotretinoin laboratory testing isn’t chopped liver! The newest frontier for biologics and psoriasis may be adherence Progress for progressive multifocal leukoencephalopathy A ‘pregnant pause’ is necessary before concluding on the obstetric risk of vitiligo Dermatologists cannot be lax about acquired cutis laxa Congenital juvenile xanthogranulomas: Born to

This month's news from across the specialty

What's hot ... December 1, 2021 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD Being a fan of the Cleveland Browns football team, I am very familiar with organizational dysfunction. It’s not

Using gene expression profiling to identify risk of melanoma metastasis

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 3, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Sancy Leachman, MD, PhD, about

Rheumatoid vasculitis? Rule-out methotrexate-associated EBV

Rheumatoid vasculitis (RV) is a serious complication of rheumatoid arthritis (RA) causing high morbidity and mortality, despite aggressive immunosuppressive treatment.

Interfering with interferon Gamma: The mechanisms behind acquired resistance to PD-1 inhibitors for melanoma

Astounding major advances in targeted therapies for melanoma, most notably by PD-1 blockade, have given hope and life to patients with metastatic melanoma. Approximately 30 % of advanced melanoma patients experience tumor responses from checkpoint blockade monotherapy, with better clinical responses seen with the combination of anti-PD-1 and anti-CTLA-4 antibodies.

Impact Report — Winter 2022

With the support of members like you, we are stepping up to meet the challenges of the specialty together. Even COVID-19 has not stopped us from raising the bar on our efforts to keep the specialty strong and your patients healthy and informed. This is the first anniversary of our

Danazol for telomerase disorders: Prolonging the end — For chromosomes (yes), for dyskeratosis congenita (perhaps)

Telomeres are located at the ends of chromosomes; they are repaired by telomerases. Shortening of telomeres leads to cell senescence, apoptosis, and chromosome instability.

Clinical guidelines disclaimer

Read the Academy's clinical guidelines disclaimer. Guidelines should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. Learn more.

Debridements

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2020 Test your knowledge: Debridements ... Take the quiz to see if you're up to date. ...

Joining forces

Go to AAD Home ... Go to AAD Home ... Menu ... Collaboration and diverse expertise strengthen clinical practice guidelines ... Collaboration and diverse expertise strengthen clinical practice guidelines ... By Jan Bowers, contributing writer Dermatologists look to the AAD’s clinical practice guidelines to serve as a roadmap for providing

Applying the 2021 E/M coding concepts in everyday practice – Part 4

Part four of the AADA’s clinical vignettes focuses on the application of coding concepts related to E/M encounters. These clinical vignettes demonstrate how chronicity and severity impacts the level of service provided.

Learning module: HIV dermatology

The purpose of the HIV dermatology learning module is to help medical students develop a clinical approach to the evaluation and initial management of HIV-positive patients presenting with skin disease.

Learning module: Dermatologic therapies

Access this learning module. The purpose of the module is to help medical students gain familiarity with common dermatologic treatments.

Necrotizing infundibular crystalline folliculitis: Not yet crystal clear

Necrotizing infundibular (ostial) crystalline folliculitis is an underrecognized disorder characterized by folliculocentric waxy papules in the seborrheic areas of adult patients. An increasing number of cases are drug related. The diagnosis requires histopathologic confirmation demonstrating intrafollicular filamentous birefringent crystalline deposits.

February 20

Learn more about February 20 at aad.org

This month’s news from across the specialty

What’s hot ... August 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to

This month's news from across the specialty

What's hot ... January 1, 2020 In this monthly column, members of  ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty.   ... MALLORY ABATE, MD Is frontal fibrosing alopecia (FFA) really caused by sunscreen? A new ... JAAD article reviews the evidence. The rising

Paraneoplastic Sarcoidosis? A Proposal to Revise and Rename the “Sarcoidosis-Lymphoma Syndrome”

When considering paraneoplastic dermatoses, several disorders come to mind, such as erythema gyratum repens, dermatomyositis, acanthosis nigricans, among others. Sarcoidosis does not. Should it?

August 26, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 26, 2020 ... Navigating immunosuppression during a pandemic: A guide for the dermatologist DW Insights and Inquiries : Topical tacrolimus topics Derm Coding Consult : Proposed Medicare fee schedule includes

February 22, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 22, 2023 ... How effective are field treatments for actinic keratosis? DermWorld Insights and Inquiries : Saving face — The importance of recognizing facial discoid dermatosis A systematic review of

April 9, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 9, 2025 ... Finasteride: Risk of depression and suicide? DermWorld Insights and Inquiries : Till death do us part — Love, marriage, and cutaneous oncology Adding oral minoxidil to standard

Moving in to first place: Antimalarials for treating generalized granuloma annulare

At a University of Pennsylvania Duhring Conference years ago, an inquiring dermatologist asked Jim Leyden how he knew the patient had generalized granuloma annulare (GGA). “It’s easy” Jim replied. “It just looks like somebody poured a box of Cheerios on them, and they stuck”. I have never seen a patient

Spot on! Lentigines in resolved psoriatic plaques

Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently, however, there have been a spate of articles

Stiff skin syndrome: Hard in many ways

Stiff skin syndrome (SSS) is a noninflammatory, fibrosing condition of the skin and fascia, often affecting the limb girdle region, notably the buttock and thighs, resulting in a lordotic posture.

A hot year, but plenty of code, too

Because you appreciate it, we continue to add to our coding resources.

Dermatology World Weekly

An archive of issues of DermWorld Weekly.

Resident Quality Improvement Award project presentations 2022

View the 2022 Resident Quality Improvement Award project presentations.

Olmsted syndrome patients can finally put their foot down

Read the January 20, 2021 DermWorld Insights and Inquiries on Olmsted syndrome.

AADA advocacy at a state level

From the President ... Dr. Taylor is the Academy’s former president. ... By Susan C. Taylor, MD, FAAD, February 1, 2026 Taking care of dermatologists so that they can take care of their patients...and their practices Dear members, ... Advocacy is a key mission of the Academy. On the federal

Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying

In the entry “Atrophic Tinea Versicolor: More Than a Mirage” (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion.

Creating pathways to navigate patient care

In June, the AAD released an update to its Guidelines of Care for the Management of Actinic Keratosis (AK) to reflect tirbanibulin research.

This month’s news from across the specialty

What’s hot ... March 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD New, but not new, but maybe new, but not good = ... Candida auris is looking worse with

New urticaria guidelines update antihistamine recommendations

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 1, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Diane Baker, MD, about a

Monitoring infantile hemangiomas: What’s the score?

Read the August 11, 2021 DermWorld Insights and Inquiries on monitoring infantile hemangiomas.

Softening the blow of calcinosis cutis: The promise of intralesional sodium thiosulfate

Calcinosis cutis (CC) is a condition in which calcium salts are deposited in the skin and subcutaneous tissue. It is classified into five main types: dystrophic, metastatic, idiopathic, iatrogenic, and calciphylaxis.

July 7, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 7, 2021 ... OTC eczema products with high prevalence of potentially allergenic ingredients DermWorld Insights and Inquiries : Progress in pemphigus — Solidifying rituximab’s role Share your comments on the

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 15, 2023 ... Platelet-rich plasma vs. minoxidil in androgenetic alopecia treatment DermWorld Insights and Inquiries : The woolly culprit — Lanolin revealed as an uncommon cause of dermatitis on normal

This month’s news from across the specialty

What’s hot ... April 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Mallory Abate,MD, FAAD Melasma is a phenotype of photodamage with a complex and multifaceted etiology involving UV radiation, visible light, hormones, and genetics,

The pachydermoperiostosis prostaglandin paradigm

Learn more about The pachydermoperiostosis prostaglandin paradigm at aad.org

Best of DermWorld Insights and Inquiries

We know how much you enjoy Dr. Heymann and the editorial board’s weekly analyses of dermatologic literature, so we’ve created a list of the top 10 most popular issues in 2025 — starting with the most popular issue of the year.

Preventing hair loss in breast cancer patients is very cool

The loss of my late aunt Millie to breast cancer was devastating; it was even harder to bear after learning that she was aware of the advancing breast tumors, but so afraid of chemotherapy that she delayed treatment until the cancer was too advanced. I do not know if it

Dupilumab and the dawn of the biologic era for atopic dermatitis

I have a list of patients with severe, recalcitrant atopic dermatitis (AD) eagerly awaiting the release of dupilumab. I first became aware of this biologic from the article by Beck et al, who noted that dupilumab, a fully humanized monoclonal antibody that blocks IL-4 and IL-13, previously reported to be

June

Issue ... June January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... How do we get dermatologic care to those who need it? What’s hot ... This month’s news from across the specialty Clinical Applications ...

Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders

Idiopathic granulomatous mastitis (IGM) should be considered in inflammatory dermatoses of the breast in women of reproductive age. The diagnosis is confirmed by ruling out inflammatory, infectious, and malignant conditions that clinically mimic the disease. There are an increasing number of reports of IGM accompanied by extramammary manifestations, notably erythema

A new chapter in vitiligo management

Recent advances in vitiligo treatment and research open doors for physicians and patients. ... Feature ... By Emily Margosian, Assistant Editor, March 1, 2024 Since the Bronze Age, humans have recorded cases of vitiligo — and attempted to cure it. ... "3,400 years ago, ancient Indian texts called the ...

AADA members and their patients bring key dermatologic issues to the Hill

At the Academy, we make it easy for your voice to be heard on the issues that matter most to your patients and practices. This year, the AADA Legislative Conference returned in-person to Capitol Hill, giving dermatologists the opportunity to bring key dermatologic issues before members of Congress. Attendees included

It’s a great time to catch a code

Coding updates and practice management remain a high priority and we’re on it! We know your practice relies on knowing which codes to use, and how and when to use them. DermWorld published more than a dozen coding titles in 2024. Some examples are listed below. Catch these codes at

No one left out in the code

As Academy members, Derm Coding Consult and DermWorld provide you with the latest information about accurate diagnostic and procedural coding, as well as Medicare reimbursement issues in dermatology.

High-dose vitamin D may be a ray of sunshine for treating sunburn

High-dose vitamin D, which has shown benefit in toxic erythema of chemotherapy and acute radiation dermatitis, may also be helpful for treating sunburn.

The newest frontier for biologics and psoriasis may be adherence

Learn more about The newest frontier for biologics and psoriasis may be adherence at aad.org

Getting the GIST cutaneous hyperpigmentation disease

By Warren R. Heymann, MD Nov. 6, 2019 Vol. 1, No. 35 Gastrointestinal stromal tumors (GISTs) are mesenchymal malignancies arising from the interstitial cells of Cajal (cells that create bioelectrical slow wave potential, leading to smooth muscle contraction, thereby aiding peristalsis). GISTs were initially recognized by identification of KIT (CD117)

For patients with erythropoietic protoporphyria the tide has come in

Read the May 12, 2021 DermWorld Insights and Inquiries on erythropoietic protoporphyria.

July 9, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 9, 2025 ... Do at-home LED devices for acne work? DermWorld Insights and Inquiries : Standard postoperative wound care practice may be all wet Academy mourns the passing of Ronald

This month’s news from across the specialty

What’s hot ... September 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Jason Lee, MD, FAAD Interobserver variability in the diagnosis of melanocytic neoplasms remains a persistent challenge in pathology. Elmore et al. in 2017 concluded

Alopecia areata incognita in Cronkhite-Canada syndrome suggests an autoimmune etiology – and that’s the way it is.

I have always been intrigued by the mysterious nature of the Cronkhite-Canada syndrome (CCS) – although I have considered the disorder in my differential diagnosis, I have never seen a case.

The role of GLP-1s in dermatology

Dermatologists discuss how the use of GLP-1s has offered potential new avenues for patients with chronic inflammatory skin diseases. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2026 Over the past five years, the approvals of glucagon-like peptide-1 receptor agonists (GLP-1s), particularly semaglutide and tirzepatide, have sparked

Joining the “fold”: Squamous cell carcinoma complicating porokeratosis ptychotropica

I know the variants of porokeratoses and can recite them as though I am the very model of a modern major general — Mibelli, linear, punctate, palmoplantar, DSAP, superficial disseminated, immunosuppression-related, and porokeratosis ptychotropica (PP).

A watershed discovery for potential treatment of pseudoxanthoma elasticum

We had the honor of presenting a family with pseudoxanthoma elasticum (PXE) at the Cooper Medical School of Rowan University session of the Philadelphia Dermatological Society on February 24th, 2017. The proband was referred to confirm the diagnosis of PXE prior to her coronary artery bypass graft surgery.

2026 Proposed Medicare Physician Fee Schedule

Access information on the proposed rule for the 2026 Medicare Physician Fee Schedule, with a focus on issues that are most important to dermatologists.

Change is inevitable

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, August 1, 2023 What drives change is often worth considering, and it’s interesting to see where change takes us. Change can occur simply as a byproduct of growth and innovation but

Expanding indications of the excimer laser for disorders of hypopigmentation: Equivocally seeing the light

The excimer laser is a reasonably effective modality for treating vitiligo. Other disorders of hypopigmentation, such as a nevus depigmentosus (ND), or post-inflammatory hypopigmentation (PIH) secondary to lichen striatus (LS) may be distressing to patients (or their parents). Is the excimer laser a viable option for these patients?

Treating acrodermatitis continua of hallopeau in 2018? Try guselkumab!

Acrodermatitis continua of Hallopeau (ACH) is a disorder well known to dermatologists, but absolutely mysterious to everyone else. It is now considered a localized form of pustular psoriasis of the digits that may be accompanied by onychodystrophy and osteolysis.

March

Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer

I have moved. How do I update my contact information with the Academy?

Asked and Answered ... March 1, 2023 AAD members can conveniently update their contact information at any time by visiting account.aad.org and selecting the ‘My Profile’ tab from the menu below. ... For additional assistance, please contact the Member Resource Center at ... mrc@aad.org or 866-503-7546. ... Looking for more

December

Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... They never taught us how to fail What's hot ... This month's news from across the specialty Clinical Applications ... Does the burden of

Keeping pace

Life-changing advances and a multidisciplinary approach give new hope to patients with Merkel cell carcinoma ... Feature ... By Allison Evans, Assistant Managing Editor, November 1, 2021 When Paul Nghiem, MD, PhD, FAAD, first started treating patients with skin cancer almost 20 years ago, physicians had little understanding of how

What's new in treating connective tissue disease

Dermatologists discuss the latest advances in treating cutaneous lupus, dermatomyositis, and systemic sclerosis. ... Feature ... By Allison Evans, Assistant Managing Editor, July 1, 2023 There are more than 200 disorders included within the term "connective tissue disease." Some of these disorders predominantly affect the skin or have skin-related implications,

Pediatric diseases in disguise

Dermatologists discuss conditions that may be harder to diagnose in children. ... Feature ... By Allison Evans, Assistant Managing Editor, October 1, 2025 Despite years of rigorous training and experience, even the best dermatologists may miss a pediatric diagnosis, particularly for dermatologists who don’t see as many pediatric patients. Some

What are the updated guidelines of care for the management of primary cutaneous melanoma?

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, December 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Susan M. Swetter, MD, and

Cosmetic complications

Dermatologists offer insight and instruction for approaching procedural afflictions. ... Feature ... By Laura Vernaci, Contributing Writer, September 1, 2025 It goes without saying that dermatologists do everything in their power to keep their patients safe and avoid complications or adverse events. However, stay in the business long enough and

Electronic consultations

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, July 1, 2019 Test your knowledge: Electronic consultations ... Take the quiz to see if you're up to date.

Definitions for the medical decision-making elements terminology

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, manager, coding and reimbursement, February 1, 2021 Academy coding staff address important coding topics each month in Derm Coding Consult. ... Read more Derm Coding Consult articles . Beginning Jan. 1, 2021, the selection of office

Lightening the cutaneous and emotional burden of melasma: Cysteamine’s role

Read the February 9, 2022 DermWorld Insights and Inquiries on cysteamine’s role in melasma.

Nonepidemic Kaposi sarcoma: The fifth dimension

By Warren R. Heymann, MD Oct. 16, 2019 Vol. 1, No. 32  ... For more than a century, since first described in 1872 by Moritz Kaposi* as "idiopathic multiple pigmented sarcoma," dermatologists focused on classical Kaposi sarcoma (KS) — violaceous patches, plaques, and tumors on the lower extremities of

Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?

Read the December 8, 2021 DermWorld Insights and Inquiries on propranolol and neutrophilic dermatoses.

Coming full circle (almost): Low dose oral minoxidil for alopecia

Read the January 5, 2022 DermWorld Insights and Inquiries on low dose oral minoxidil for alopecia.

Insult to injury: COVID-19-associated mucormycosis

Read the June 9, 2021 DermWorld Insights and Inquiries on COVID-19-associated mucormycosis.

What is the path forward for treating children with severe atopic dermatitis with dupilumab?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, March 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy Paller, MD, about her

CMS finalizes and implements evaluation and management visit complexity HCPCS add-on code G2211

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, May 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . CMS has officially implemented the novel

This month's news from across the specialty

What's hot ... September 1, 2021 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Bryan Carroll, MD, PhD, FAAD The parable of the blind men and the elephant speaks to the limitations of an individual’s perception in

Men in the Twilight Zoon

Read the February 19, 2020 DermWorld Insight and Inquiries on treating Zoon balanitis.

State law and teratogenic medications

Patient access to teratogenic medications may be impacted by state abortion access laws. The Academy has resources for members who prescribe teratogenic medications, and for patients who may need access to reproductive health services.

Knuckling down on knuckle pads

Read the April 1, 2020 DermWorld Insight and Inquiries on knuckle pads.

On the cusp of extraordinary advances in extramammary Paget disease

Read the May 27, 2020 DermWorld Insights and Inquiries on EMPD.

Does the JAK inhibitor baricitinib raise the bar on treating lupus?

Undeniably, the JAK inhibitors have been at the forefront of advances in immunologically-based diseases, including alopecia areata, vitiligo, psoriasis, rheumatoid arthritis, atopic dermatitis, graft-versus-host disease, and other disorders.

Ustekinumab: A topic for atopics?

If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of dupilimab (a human monoclonal antibody against interleukin-4 receptor alpha, that inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of

Becker’s nevus: Mutations that shoulder responsibility

It is fascinating to review original articles. In 1949, Becker described two young men, aged 17 and 24, respectively, with “blotchy” brown pigmentation with dark hairs, on the shoulder region, first noting their lesions in their early to mid teens. Both patients had their lesions follow an intense sunburn, allowing

Mucho de Mucha-Habermann

As we approach interview season for our residency program, I try to think of some questions I haven’t asked before. I usually do not discuss dermatologic disorders per se, as I am more concerned about the interviewee as a person knowing how they would mesh in our division.

Mindfulness for the patient and the dermatologist

While meditation has been present for millennia, the concept of mindfulness has recently come into vogue. Conceptually, mindfulness aims to have a person focus their attention on the present moment by developing coping strategies, such as meditation or deep breathing.

February 9, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 9, 2022 ... Tinted sunscreens: A practical guide to counseling patients DermWorld Insights and Inquiries : Lightening the cutaneous and emotional burden of melasma — cysteamine’s role Nemolizumab plus topicals

January 25, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 25, 2023 ... Is topical spironolactone effective for acne? DermWorld Insights and Inquiries : The ironclad promise of ferroptosis Topical lidocaine-prilocaine vs. ice packs for laser hair removal Efficacy of

August 17, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 17, 2022 ... Do dietary exclusions improve atopic dermatitis? DermWorld Insights and Inquiries : Promising therapeutic developments for cutaneous lupus erythematosus — Interfering with interferon Derm Coding Consult : Dermatology

May 3, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 3, 2023 ... Oral oxybutyloride for hidradenitis suppurativa patients? DermWorld Insights and Inquiries : Necrobiosis lipoidica in a Wink Exposure to anesthesia and alopecia areata Do study authors accurately report

April 8, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 8, 2026 ... Does oral spironolactone improve acne in women? DermWorld What’s Hot: mRNA COVID vaccine and immune checkpoint inhibitor response Herbal medicines for psoriasis Efficacy of PDT and fractional

August 26, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 26, 2026 ... Do collagen peptides affect skin aging? DermWorld What’s Hot: Saline for plantar warts Second-generation antihistamines in dermatology A treatment for dark circles? Impact of weight-loss interventions on

It’s been six months! Here’s what the Academy has done for you…

From the President ... Dr. Kaufmann served as Academy president from March 2022 to March 2023. ... By Mark Kaufmann, MD, FAAD, September 1, 2022 It feels like just yesterday that more than 15,000 of us attended the 2022 AAD Annual Meeting in Boston, and it’s hard to believe that

Determining the appropriate lesion destruction code — benign or premalignant

Derm Coding Consult ... By Tiffany McFarland, RHIT, Analyst, Coding & Reimbursement, April 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The distinctions of code choice for lesion destruction — either benign, premalignant, or malignant

Herpes zoster, immunosuppression, and vaccination: Far from a blistering pace

I had long promised myself that I would get Zostavax when I turned 60. Now 61, I am actively procrastinating – I decided to wait for a new VZV subunit zoster vaccine that consists of recombinant VZV glycoprotein E and a liposome-based ASO1B adjuvant system.

Desquamative gingivitis: Sinking your teeth in miagnosis and management

Patients presenting with desquamative gingivitis (DG) are typically some of the most frustrated, aggravated patients I encounter. Frequently, they have not been adequately evaluated, are in pain, and are desperate for help.

January

Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... More unintended consequences What's hot ... This month's news from across the specialty Clinical Applications ... What is the economic burden of drug utilization

March

Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I called a colleague the other day to discuss a patient What's hot ... This month's news from across the specialty Clinical Applications ...

March

Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... March is a strange month What's hot ... This month's news from across the specialty Clinical Applications ... What is the path forward for

Melanoma clinical guideline

Access information on the Academy's guidelines of care for melanoma. This page provides convenient, at-a-glance highlights from the full guidelines, providing dermatologists with the most important clinical information.

Quick coding guides

Download these coding tip sheets for practical guidance on common coding. The coding tip sheets include resources on ICD-10, E/M codes, CPT codes, and modifiers. Download them and use them on the go.

How do I pay my dues? Can I get a receipt for paying my dues?

Asked and Answered ... November 1, 2022 AAD members can pay their dues and access their membership dues receipt by visiting their account page ( ... account.aad.org ), and selecting from the menu below: ... How do I get a receipt for other payments made to the Academy? ... For

Risk factors for herpes zoster: Age, immunosuppression, and…statins?

When I started my residency 37 years ago, I never would have imagined that nearly four decades later, I would be baffled by patients and their rashes every day. When I’m stumped diagnostically, I admit it (to myself and the patient), hope that either the disease will manifest recognizable features,

Tarrying for tapinarof

Read the January 12, 2022 DermWorld Insights and Inquiries on tapinarof.

A potential roadMAP for treating malignant atrophic papulosis

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, June 1, 2026 Vol. 8, No. 6 Certain skin lesions evoke dread in the dermatologist who encounters them, fearing a poor prognosis for their patient. Examples include a Sister Mary Joseph nodule, a thick melanoma, or rhinocerebral mucormycosis, among

Postmortem: AADA Legislative Conference

From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, November 1, 2021 Postmortem : "examination of a dead body," or "process of evaluating success (or failure) of a project’s ability to meet its goals." Given that definition,

February 23, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 23, 2022 ... Frontal fibrosing alopecia: The effects of sunscreens and moisturizers DermWorld Insights and Inquiries : The vexing verruciform xanthoma DermWorld Young Physician Focus : The patient experience —

April 13, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 13, 2022 ... Is there an association between isotretinoin and adverse neuropsychiatric outcomes? DermWorld Insights and Inquiries : Early recognition of rituximab-induced late onset neutropenia is essential 2022 Academy election

November 8, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 8, 2023 ... Terbinafine for onychomycosis: Continuous- vs. pulse-dose DermWorld Insights and Inquiries : NSA (neutrophilic sebaceous adenitis) secrets revealed AAD releases updated guidelines for atopic dermatitis FDA approves secukinumab

February 10, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 10, 2021 ... FDA clears device to improve cellulite DermWorld Insights and Inquiries: Leishmania episode 1a — attack of the clones Distance traveled: Dr. Lim’s diversity focus as Academy president

February 28, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 28, 2024 ... Ciclosporin vs. methotrexate for young patients with atopic dermatitis DermWorld Insights and Inquiries : Taming toxic erythema of chemotherapy with high-dose vitamin D Moisturizing cream with 20%

April 30, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 30, 2025 Efficacy of spironolactone in treating patients with acne DermWorld Insights and Inquiries : A tale of two disorders of hypopigmentation — The potential role of Cutibacterium acnes dysbiosis

Your Dermatologist Knows media wins 2023

See key highlights of media wins for Your Dermatologist Knows from 2023. We consider every new story published as a result of our pitches as a win, regardless of whether it’s in the local paper of a small town or front-page news in a major national outlet.

What can dermatologists do to prevent squamous cell carcinoma in solid organ transplant recipients?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, January 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Anokhi Jambusaria, MD,

Storytelling in advocacy

Ask the Expert ... By Victoria Houghton, Managing Editor, February 1, 2023 DermWorld ... spoke to Alex Gross, MD, FAAD, chair of the AADA State Policy Committee, about how to utilize personal stories with policymakers to make an advocacy impact. DermWorld: Tell us about your experience advocating on behalf of

Where do Americans get pricing information for health care services?

Facts at your Fingertips ... By Emily Margosian, Assistant Editor, November 1, 2022 New survey data released this year by Akasa, a health care AI developer, found that Americans most often turn to health insurers for pricing information over other sources, placing new emphasis on the need for price transparency

What's hot?

What's hot ... June 28, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... "SPF 30 or higher" is the classic, impulse response that we often give when asked about sunscreen recommendations. However,

Brentuximab vedotin update and the #MeToo saga of the Reed-Sternberg cell

There has been increasing dermatological literature about the use of brentuximab vedotin (BV) for a variety of CD30+ cutaneous lymphomas. The thrust of this commentary is to examine the current reports about BV.

'Stepping up' to off-label dosing of biologics

Read the April 6, 2022 DermWorld Insights and Inquiries on off-label dosing of biologics.

What's hot?

What's hot ... August 23, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Are you over-checking labs for your acne patients on isotretinoin? An article from the ... JAAD’ s Best of

Coding and documentation for hyperhidrosis

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Clear and concise documentation is essential

Patient advocate resources

Find a wealth of resources for patient advocates, including links to support groups. There are patient education resources, inspiring patient stories, and more.

Your Dermatologist Knows: Media wins

One of the largest successes was the widespread media coverage of a recent Journal of the American Academy of Dermatology study which found that men — particularly men with skin of color — are more likely to die from melanoma.

Additional boards resources

Looking for more study tools? Residents and Fellows Committee members have recommend the following resources when preparing for the boards.

I’m not sure how to correctly code with the new 2021 E/M coding guidelines. What resources does the Academy offer?

Asked and Answered ... March 1, 2021 Members can find a high-level summary on what dermatologists need to know about the ... restructured E/M codes in the AAD’s Coding Resource Center. ... The AAD also offers an updated ... E/M coding tool , designed to reflect the revised tenets of

Tracking teledermatology: Before and after COVID

Facts at your fingertips ... By Emily Margosian, assistant editor, March 1, 2021 This month marks the one-year anniversary of the shutdown of schools, businesses, and medical practices in response to COVID-19. While teledermatology was not widely utilized prior to the start of the pandemic, it became a key part

Patient power

Technology amplifies the patient voice in advocacy groups ... Feature ... By Jan Bowers, Contributing Writer, February 1, 2022 In the early 20th century, when a diagnosis of cancer almost inevitably led to death, a group of 10 physicians and five laypeople launched the American Society for the Control of

Redefining necessity

Experts discuss efforts to obtain coverage for skin conditions that payers classify as "cosmetic." ... Feature ... By Ruth Carol, Contributing Writer, August 1, 2026 When insurance companies categorize skin conditions as "cosmetic," they aren’t considering the psychological impact, physical discomfort, and functional impairment that are often associated with the

Not the usual suspects

Go to AAD Home ... Go to AAD Home ... Menu ... Drugs you never thought you’d use in dermatology ... Drugs you never thought you’d use in dermatology ... By Jan Bowers, contributing writer   ... Young dermatologists quickly become familiar with mainstays of treatment such as antibiotics,

An old dog with a new trick: High dose intralesional steroids in hidradenitis suppurativa

Read the February 2, 2022 DermWorld Insights and Inquiries on high dose intralesional steroids in hidradenitis suppurativa.

Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future

MEK inhibition may be a new therapeutic pathway to treat disorders demonstrating focal acantholytic dyskeratosis, including Darier disease and Grover disease.

Get your KICS on Route IL-6

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome caused by hypercytokinemia (notably Th1 cytokines — interferon-gamma, tumor necrosis factor-alpha, and IL-6). Clinical manifestations are dramatic, presenting as fever, hepatosplenomegaly, hemophagocytosis, and cytopenias. (See the addendum for diagnostic criteria of HLH). Primary forms of HLH are genetic disorders; secondary HLH is

Psoriasin: Its other meaning and implications

Biologic processes are akin to world-class orchestras requiring precise coordination between the conductor and musicians. One miscue by either can spoil the performance.

Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?

Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an “ill-defined papular eruption” of the trunk and an erosion of the posterior pharynx. Routine microscopy demonstrated a

Coming to an ICU Near You — Candida auris

I first became aware of Candida auris (C. auris) during my 96 year-old mother’s most recent hospitalization in New York for congestive heart failure.

June 9, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 9, 2021 ... Merkel cell carcinoma survival by anatomic site DermWorld Insights and Inquiries: Insult to injury — COVID-19-associated mucormycosis Microneedling with topical therapies for melasma Photosensitivity reaction from benzodiazepines

February 8, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 8, 2023 ... A review of newer agents for alopecia areata DermWorld Insights and Inquiries : A surgeon’s primary intention is to reduce secondary infection CDC investigating possibility of treatment-resistant

July 17

Learn more about July 17 at aad.org

June 1, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 1, 2022 ... What’s new in adult acne over the last two years? DermWorld Insights and Inquiries : Granulomatous cheilitis — Back to the Future Derm Coding Consult : Cigna’s

February 14, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 14, 2024 ... Topical tofacitinib for lichen planopilaris, frontal fibrosing alopecia DermWorld Insights and Inquiries : Caveat mTOR revisited — Neurofibromatosis Risk factors for development of tinea pedis, onychomycosis Mpox

July 27, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 27, 2022 ... Facial hyperhidrosis: Botulinum toxin A injection vs. topical glycopyrrolate DermWorld Insights and Inquiries : JAKne is on the horizon Dupilumab for chronic prurigo, chronic idiopathic pruritus Safety

December 11, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 11, 2024 ... Consensus guidelines for off-label use of oral minoxidil for hair loss DermWorld Insights and Inquiries : Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders Diagnostic

March 6, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 6, 2024 ... Benzyl benzoate vs. permethrin in treating scabies DermWorld Insights and Inquiries : Hemochromatosis — Beyond 50 shades of gray Oral acitretin plus topical triamcinolone vs. topical triamcinolone

November 12, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 12, 2025 ... Efficacy of OTC androgenetic alopecia therapies vs. FDA-approved monotherapies DermWorld Insights and Inquiries : JAK inhibitors battle in the heavyweight class Is there increased psoriasis risk in

2026 Final Medicare Physician Fee Schedule

Access information on the final rule for the 2026 Medicare Physician Fee Schedule, with a focus on issues that are most important to dermatologists.

‘And miles to go before I sleep…’

From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, March 1, 2022 Holidays over, now the new year, perhaps an early spring, but unlikely… ... From the streets of Brooklyn to the pinnacle of the specialty —

Dupilumab’s conjunctivitis conundrum

Having worn glasses since kindergarten, and being virtually helpless without them, I am particularly sympathetic to patients with eye disorders.

Americans lack basic health insurance literacy

Facts at your Fingertips ... By Emily Margosian, Assistant Editor, March 1, 2023 A recent Forbes Advisor survey of 2,000 Americans who have health insurance found that while most policyholders report they’re happy with their coverage, many don’t understand it.According to the survey, over three-quarters of participants were unable to

Practice management licensing opportunities

Navigating the health care environment can be tricky and difficult to understand. We've designed our practice management content to provide practical, easy-to-understand tools and guidance to help in a variety of areas, including coding and reimbursement, and MIPS.

2026 quality measures for MIPS reporting

Learn about 2026 quality measures for MIPS reporting. This page provides measure specifications for all dermatology-specific measures that can be reported for MIPS. Select the measure number to access the specifications.

Chanarin-Dorfman syndrome: Shifting out of neutral

Lipid vacuoles (Jordans’ anomaly) in white blood cells in patients with ichthyotic disorders (resembling nonbullous congenital erythroderma or the erythrokeratodermas) are indicative — but not pathognomonic — of the Chanarin-Dorfman syndrome. In documented cases of CDS, acitretin may be used with caution.

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.  

Managing menopause

Dermatologists discuss dermatologic changes before and during menopause and the dermatoses that may occur. ... Feature ... By Allison Evans, Assistant Managing Editor, December 1, 2025 Menopausal transitions can be stressful. While rapidly declining estrogen levels can wreak havoc internally, many of these changes involve the skin, hair, and vulvar

DataDerm: A year of growth

Facts at your fingertips ... By Emily Margosian, Assistant Editor, March 1, 2022 The largest clinical registry of dermatologic patients in the world, the Academy’s DataDerm ... TM ... platform, housed data from over 11 million patients as of Dec. 31, 2020, according to a recently published ... JAAD article

Juvenile lichen sclerosus: A loss of innocence

Read the August 17, 2020 DermWorld Insights and Inquiries on juvenile lichen sclerosus.

Cellular neurothekeoma: A tribute to Barnhill and Mihm and a remembrance of Martin C. Mihm Jr., MD

Cellular neurothekeomas are benign lesions of presumed fibrohistiocytic origin. Rendering this diagnosis is essential to avoid misdiagnosis and potential overtreatment.

Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod

Read the June 2, 2021 DermWorld Insights and Inquiries on contact pemphigus and pemphigus-like eruptions due to imiquimod.

A single case report has the potential to change the world: Could JAK inhibition alter the trajectory of multicentric reticulohistiocytosis?

Read the July 20, 2022 DermWorld Insights and Inquiries on JAK inhibition and multicentric reticulohistiocytosis.

The treatment of systemic juvenile xanthogranulomas matures

Advances in genetics and molecular biology have identified pathways confirming the usefulness of targeted therapies such as dabrafenib and alectinib in those patients with systemic juvenile xanthogranulomas harboring specific mutations in BRAF or ALK translocations, respectively.

Caveat mTOR revisited: Neurofibromatosis

Targeting the MAPK/ERK and PI3K/AKT/mTOR pathway has led to the use of topical sirolimus for neurofibromas and oral selumetinib for children with plexiform neurofibromas.

This month’s news from across the specialty

What’s hot ... August 1, 2022 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MPH, MSBS, FAAD You have likely noticed an increase in online reviews of yourself and your practice over the last

Elmer Fudd beware: Tularemia’s re-emergence

Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her face, trunk, and extremities (diagnosed as erythema multiforme minor).

Teprotumumab: An eye-opening advance for pretibial myxedema?

Having just completed the chapter on the treatment of pretibial myxedema (PTM, also known as thyroid dermopathy) for the upcoming 5th edition of Treatment of Skin Disease (which I edit with my esteemed colleagues Mark Lebwohl, John Berth-Jones, and Ian Coulson), I am amazed at how little progress there has

Calcineurin inhibitors under occlusion – I could’ve had a V8!

I have used topical steroids under occlusion for as long I have been in dermatology. What a fabulous maneuver this is for difficult to treat dermatoses such as lichen simplex chronicus, recalcitrant psoriasis, or hypertrophic lichen planus, etc.

2017’s management of Stevens-Johnson/toxic epidermal necrolysis: The pendulum is swinging

As in any controversial subject, it is essential to sort out areas of consensus versus disagreement. Most dermatologists would recommend managing Stevens-Johnson syndrome/Toxic Epidermolysis Necrolysis (SJS/TEN) by eliminating the culprit drug, monitoring fluid and electrolytes, being vigilant for secondary infection, and adhering to strict wound care, possibly in a burn

February 12, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 12, 2020 ... FDA prioritizes drug shortages with new approval policy DW Insights and Inquiries : Twenty years of imiquimod taking its toll on lentigo maligna: Where are we? CMS

February 16, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal